Skip to main content

METALOFARMACOS MULTIFUNCIONALES PARA DIAGNOSIS Y TERAPIA

RED2018-102471-T

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Redes Investigación /Redes Excelencia
Call year 2018
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 72
Encontrada(s) 1 página(s)

Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publication Artículo científico (JournalArticle)

Exploring the Biological Properties of Zn(II) Bisthiosemicarbazone Helicates

  • Fernández-Fariña, Sandra
  • Velo Heleno, Isabel
  • Carballido, Rocío
  • Martínez-Calvo, Miguel
  • Barcia Vieitez, Ramiro
  • Palacios, Òscar
  • Capdevila, Mercè
  • González Noya, Ana María
  • Pedrido Castiñeiras, Rosa
The design of artificial helicoidal molecules derived from metal ions with biological properties is one of the objectives within metallosupramolecular chemistry. Herein, we report three zinc helicates derived from a family of bisthiosemicarbazone ligands with different terminal groups, Zn2(LMe)2∙2H2O 1, Zn2(LPh)2∙2H2O 2 and Zn2(LPhNO2)2 3, obtained by an electrochemical methodology. These helicates have been fully characterized by different techniques, including X-ray diffraction. Biological studies of the zinc(II) helicates such as toxicity assays with erythrocytes and interaction studies with proteins and oligonucleotides were performed, demonstrating in all cases low toxicity and an absence of covalent interaction with the proteins and oligonucleotides. The in vitro cytotoxicity of the helicates was tested against MCF-7 (human breast carcinoma), A2780 (human ovarian carcinoma cells), NCI-H460 (human lung carcinoma cells) and MRC-5 (normal human lung fibroblasts), comparing the IC50 values with cisplatin. We will try to demonstrate if the terminal substituent of the ligand precursor exerts any effect in toxicity or in the antitumor activity of the zinc helicates
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publication Artículo científico (JournalArticle)

Schiff Bases Functionalized with T-Butyl Groups as Adequate Ligands to Extended Assembly of Cu(II) Helicates

  • Fernández-Fariña, Sandra
  • Velo Heleno, Isabel
  • Martínez-Calvo, Miguel
  • Maneiro Maneiro, Marcelino
  • González Noya, Ana María
  • Pedrido Castiñeiras, Rosa
The study of the inherent factors that influence the isolation of one type of metallosupramolecular architecture over another is one of the main objectives in the field of Metallosupramolecular Chemistry. In this work, we report two new neutral copper(II) helicates, [Cu2(L1)2]·4CH3CN and [Cu2(L2)2]·CH3CN, obtained by means of an electrochemical methodology and derived from two Schiff-based strands functionalized with ortho and para-t-butyl groups on the aromatic surface. These small modifications let us explore the relationship between the ligand design and the structure of the extended metallosupramolecular architecture. The magnetic properties of the Cu(II) helicates were explored by Electron Paramagnetic Resonance (EPR) spectroscopy and Direct Current (DC) magnetic susceptibility measurements
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Time‐dependent cytotoxic properties of terpyridine‐based copper complexes

  • Grau, Jordi
  • Caubet, Amparo
  • Roubeau, Olivier
  • Montpeyó, David
  • Lorenzo, Julia
  • Gamez, Patrick
Five copper complexes supported by terpyridine ligands were prepared and characterized, viz. [Cu3Cl4(naphtpy)2][CuCl2] (1), [Cu2Cl2(naphtpy)2](ClO4)2 (2), [CuCl2(naphtpy)]2(MeOH)3(H2O) (3), [CuCl2(Cltpy)] (4) and [Cu(Cltpy)2](ClO4)2 (5); (where naphtpy stands for 4’‐((naphthalen‐2‐yl)methoxy)‐2,2′:6′,2′′‐terpyridine and Cltpy for 4′‐chloro‐2,2′:6′,2′′‐terpyridine). Their ability to interact with DNA was investigated, and their cytotoxic behaviour was examined with three cells lines, namely human ovarian carcinoma cells (A2780), their derived cisplatin‐resistant line (A2780cis), and human cervix adenocarcinoma cells (HeLa). All compounds show good cytotoxic properties (especially after 72 h of incubation). Remarkably, two compounds, 4 and 5, are still almost inactive after 24 h (particularly 4), but are highly active after 72 h, with IC50 values in the low‐micromolar to sub‐micromolar range. Compounds 1 and 2 induce necrosis, whereas late apoptosis is observed with 3–5, 4 exhibiting a behaviour close to that of cisplatin., Financial support from the Spanish Ministerio de Ciencia Innovación, y Universidades (Projects CTQ2017‐88446‐R AEI/FEDER, UE, RED2018‐102471‐T and RTI2018‐098027‐B‐C22) is kindly acknowledged. P.G. acknowledges the Institució Catalana de Recerca i Estudis Avançats (ICREA)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Luminescent Re(I)/Au(I) species as selective anticancer agents for HeLa cells

  • Luengo, Andrés
  • Redrado, Marta
  • Marzo, Isabel
  • Fernández-Moreira, Vanesa
  • Gimeno, M. Concepción
A series of neutral and cationic heterotrimetallic complexes of the type fac-[Re(CO)3(bipy(CC)2-(AuL)2)X]n, where bipy(CC)2 is 4,4′-alkynyl-2,2′-bipyridine; L is either triphenylphosphine (PPh3), [1,3-bis(2,6-diisopropylphenyl)-imidazol-2-ylidene] (IPr), or tert-butyl isocyanide (CNtBu); and X is a chloride (n = 0) or acetonitrile (n = 1), were synthesized and characterized together with their Re(I) precursors, i.e., fac-[Re(CO)3(bipy(CC)2)X]n. X-ray diffraction of complexes 1, 3, and 6 corroborated the expected octahedral and linear distribution of the ligands along the Re(I) and Au(I) centers, respectively. Luminescent studies showed that all the complexes displayed a broad emission band centered between 565 and 680 nm, corresponding to a 3MLCT from the Re(I) to the diimine derivative. The presence of the gold fragment coordinated to the diimine ligand shifted in all cases the emission maxima toward higher energies. Such an emission difference could be potentially used for assessing the precise moment of interaction of the probe with the biological target if the gold fragment is implicated. Antiproliferative studies in cancer cells, A549 (lung cancer) and HeLa (cervix cancer), showed a generalized selectivity toward HeLa cells for those heterotrimetallic species incubated at longer times (72 vs 24 h). ICP-MS spectrometry revealed the greater cell internalization of cationic vs neutral species. Preliminary fluorescence microscopy experiments showed a different behavior of the complexes in HeLa and A549 cell lines. Whereas the complexes in A549 were randomly distributed in the outside of the cell, those incubated with HeLa cells were located close to the cellular membrane, suggesting some type of interaction, and possibly explaining their cellular selectivity when it comes to the antiproliferative activity displayed in the different cell lines., The authors thank the Ministerio de Economı́a y Competitividad (MINECO-FEDER CTQ2016-75816-C2-1-P), the Ministerio de Ciencia Innovación y Universidades (RTI2018-097836-J-I00 and RED2018-102471-T), and Gobierno de Aragón-Fondo Social Europeo (E07_20R) for financial support. A.L. and M.R. thank the Gobierno de Aragón for a predoctoral fellowship., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Gold(I) and silver(I) complexes with 2-anilinopyridine-based heterocycles as multitarget drugs against colon cancer

  • Mármol, Inés
  • Montanel-Pérez, Sara
  • Royo, José Carlos
  • Gimeno, M. Concepción
  • Villacampa, M. Dolores
  • Rodríguez-Yoldi, María Jesús
  • Cerrada, Elena
A series of gold(I) and silver(I) derivatives with N- or S-donor ligands derived from 2-anilinopyridine has been synthesized and characterized. The mononuclear structure of [Au(L1)(PPh3)](TfO) (1a) and [Au(L2)(PPh3)](TfO) (1b) was confirmed by X-ray diffraction studies, as well as the dinuclear structure in the case of [Ag(TfO)(L1)]2 (4a). Most of the complexes are cytotoxic against a model of colorectal adenocarcinoma (Caco-2 cell line) and breast adenocarcinoma cancer cell lines (MCF-7). [Au(L1)(PPh3)](TfO) (1a) was able to induce caspases 8 and 3 activation, loss of mitochondrial membrane potential, and reactive oxygen species (ROS)-dependent cell death on Caco-2 cells upon 24 h incubation. In addition, the gold complex 1a produced a significant inhibition of the redox enzyme thioredoxin reductase as well as 20S proteasome. However, the silver(I) analogue, [Ag(TfO)(L1)(PPh3)] (2a), induced cell death independent of inhibition of thioredoxin reductase and 20S proteasome, triggered ROS-independent apoptosis mediated by caspase 8 and 3 activation, and loss of mitochondrial membrane potential, which points to a different mechanism of action for both derivatives, dependent on the metal center., We thank The Ministerio de Economı́a y Competitividad (Grants CTQ2016-75816-C2-1-P, PID2019-104379RB-C21, and SAF2016-75441-R), CIBEROBN under Grant CB06/03/1012 of the Instituto Carlos III, European Grant Interreg/SUDOE (Redvalue, SOE1/PI/E0123), Red Multimetdrugs (Grant RED2018-102471-T), and Aragon Regional Government (Grants B16_R17 and E07_20R) for financial support., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Heterobimetallic propargyl gold complexes with π-bound copper or silver with enhanced anticancer activity

  • Johnson, Alice
  • Marzo, Isabel
  • Gimeno, M. Concepción
Several propargyl functionalised substrates with different heteroatoms (N, O or S) have been used for the preparation of propargyl gold(I) phosphine complexes. The complexes were prepared in high yields either by reaction of the substrate with [Au(acac)PPh3] or by reaction of [AuCl(PPh3)] with potassium hydroxide and the substrate in methanol. Several of the complexes have been characterised by X-ray diffraction showing the presence of secondary bonds such as π-stacking and aurophilic interactions. The reaction of the propargyl gold(I) phosphine complexes with [Cu(NO3)(PPh3)2] or [Ag(OTf)(PPh3)2] afforded heterobimetallic complexes with π-coordination of {Cu(PPh3)2} or {Ag(PPh3)2} to the alkyne bond. When the substituent of the propargyl unit contained more strongly coordinating pyridine moieties, [(PyCH2)2NCH2C[triple bond, length as m-dash]CAuPPh3], coordination of the heterometal to the pyridine units occurred, displacing the phosphine groups and giving rise to a dimeric structure. The antiproliferative activity of the complexes against cisplatin resistant lung cancer cell line A549 was determined by MTT assay. The mononuclear gold complexes showed excellent activities with IC50 values < 14 μM. Coordination of copper of silver to the alkynyl fragment resulted in a significant increase in activity suggesting a synergistic effect between the two metal centres., The authors also thank Ministerio de Investigación e Invovación (CTQ2016-75816-C2-1-P, PID2019-104379RB-C21 and RED2018-102471-T) and Gobierno de Aragón-Fondo Social Europeo (Research Group E07_20R) for financial support of our research., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Luminescent bimetallic IrIII/AuI peptide bioconjugates as potential theranostic agents

  • Luengo, Andrés
  • Marzo, Isabel
  • Reback, Matthew
  • Daubit, Isabelle M.
  • Fernández-Moreira, Vanesa
  • Metzler-Nolte, Nils
  • Gimeno, M. Concepción
Diverse iridium peptide bioconjugates and the corresponding iridium/gold bimetallic complexes have been synthesized starting from a cyclometallated carboxylic acid substituted IrIII complex [Ir(ppy)2(Phen‐5‐COO)] by solid phase peptide synthesis (SPPS). The selected peptide sequences were an enkephalin derivative Tyr‐Gly‐Gly‐Phe‐Leu together with the propargyl‐substituted species Tyr‐Gly‐Pgl‐Phe‐Leu to allow gold coordination (Pgl: propyrgyl‐glycine, HC≡C‐Gly), and a specific short peptide, Ala‐Cys‐Ala‐Phen, containing a cysteine residue. Introduction of the gold center has been achieved via a click reaction with the alkynyl group leading to an organometallic Au−C(triazole) species, or by direct coordination to the sulfur atom of the cysteine. The photophysical properties of these species revealed predominantly an emission originating from the Ir complex, using mixed metal‐to‐ligand and ligand‐to‐ligand charge transfer excited states of triplet multiplicity. The formation of the peptide bioconjugates caused a systematic redshift of the emission profiles. Lysosomal accumulation was observed for all the complexes, in contrast to the expected mitochondrial accumulation triggered by the gold complexes. Only the cysteine‐containing Ir/Au bioconjugate displayed cytotoxic activity. The absence of activity may be related to the lack of endosomal/lysosomal escape for the cationic peptide conjugates. Interestingly, the different coordination sphere of the gold atom may play a crucial role, as the Au−S(cysteine) bond may be more readily cleaved in a biological environment than the Au−C(triazole) bond, and thus the Au fragment could be released from or trapped in the lysosomes, respectively. This work represents a starting point in the development of bimetallic peptide bioconjugates as theranostics and in the knowledge of factors that contribute to anti‐proliferative activity., Authors thank the Ministerio de Ciencia Innovación (projects CTQ2016‐75816‐C2‐1‐P, PID2019‐104379RB‐C21, RTI2018‐097836‐J‐I00, RYC2018‐025872‐I and RED2018‐102471‐T) and Gobierno de Aragón‐Fondo Social Europeo (E07 20R) for financial support. A. L. thanks the Gobierno de Aragón for a predoctoral fellowship as well as Universidad de Zaragoza, Fundación Bancaria Ibercaja and Fundación Cai for a doctoral stay fellowship (CB 7/17)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Novel ureido-dihydropyridine scaffolds as theranostic agents

  • Auria-Luna, Fernando
  • Marqués-López, Eugenia
  • Romanos, Eduardo
  • Fernández-Moreira, Vanesa
  • Gimeno, M. Concepción
  • Marzo, Isabel
  • Herrera, Raquel P.
In this work, the synthesis of interesting urea derivatives 5 based on 1,4-dihydropyridines 3 is described for the first time. Considering that both families exhibit potential as drugs to treat various diseases, their activity as anticancer agents has been evaluated in HeLa (cervix), Jurkat (leukaemia) and A549 (lung) cancer cell lines as well as on healthy mice in vivo. In general, whereas 1,4-dihydropyridines show a moderate cytotoxic activity, their urea analogues cause an extraordinary increase in their antiproliferative activity, specially towards HeLa cells. Because of the chiral nature of these compounds, enantiomerically enriched samples were also tested, showing different cytotoxic activity than the racemic mixture. Although the reason is not clear, it could be caused by a complex amalgam of physical and chemical contributions. The studied compounds also exhibit luminescent properties, which allow performing a biodistribution study in cancer cells. They have emission maxima between 420 and 471 nm, being the urea derivatives in general red shifted. Emission quenching was observed for those compounds containing a nitro group (3e,f and 5e,f). Fluorescence microscopy showed that 1,4-dihydropyridines 3a and 3g localised in the lysosomes, in contrast to the urea derivatives 5h that accumulated in the cell membrane. This different distribution could be key to explain the differences found in the cytotoxic activity and in the mechanism of action. Interestingly, a preliminary in vivo study regarding the acute toxicity of some of these compounds on healthy mice has been conducted, using a concentration up to 7200 times higher than the corresponding IC50 value. No downgrade in the welfare of the tested mice was observed, which could support their use in preclinical tumour models., This work was supported by a 2018 Leonardo Grant for Researchers and Cultural Creators, BBVA Foundation, Ministerio de Economía, Industria y Competitividad (MINECO-FEDER CTQ2016-75816-C2-1-P, CTQ2017-88091-P, PID2019-104379RB-C21, RTI2018-097836-J-I00, RYC2018-025872-I and RED2018-102471-T) and Gobierno de Aragón-Fondo Social Europeo (Research Group E07_20R)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Self‐assembly of hollow organic nanotubes driven by arene regioisomerism

  • Alegre-Requena, Juan V.
  • Herrera, Raquel P.
  • Díaz Díaz, David
Arene regioisomerism in low‐molecular‐weight gelators can be exploited as a tool to modulate the micro‐structures of the corresponding xerogel networks by using the three different possible substitution patterns ortho, meta and para. This aromatic regioisomer‐driven strategy has been used with a cholesterol‐based gelator to prepare hollow self‐assembled organic nanotubes (S‐ONTs) with inside and outside diameters of ca. 35 and 140 nm, respectively. Electron microscopy imaging and theoretical calculations were employed to rationalize the formation mechanism of these S‐ONTs. From the three possible regioisomers, only the ortho‐disubstituted cholesteryl‐based gelator showed the optimal angle and distance between substituents to afford the formation of the cyclic assemblies required for nanotube growth by assembling 30–40 units of the gelator. This study opens fascinating opportunities to expand the synthesis of controllable and unique microstructures by modulating geometrical parameters through aromatic regioisomers., Financial support from the Deutsche Forschungsgemeinschaft (DFG, Heisenberg Professorship to D.D.D.), Universität Regensburg and BBVA Foundation (2018 Leonardo Grant for Researchers and Cultural Creators to R.P.H.). R.P.H. also thanks Ministerio de Economía, Industria y Competitividad (MINECO‐FEDER CTQ2017‐88091‐P and RED2018‐102471‐T) and Gobierno de Aragón‐Fondo Social Europeo (Research Group E07_20R) for financial support. J.V.A.‐R. thanks the Government of Aragon (DGA) for a predoctoral contract. We acknowledge the Extreme Science and Engineering Discovery Environment (XSEDE) allocation TG‐CHE190111. D.D.D. thanks the Spanish Ministry of Science, Innovation and Universities for the Senior Beatriz Galindo Award (Distinguished Researcher; BEAGAL18/00166). D.D.D. thanks NANOtec, INTech, Cabildo de Tenerife and ULL for laboratory facilities. Open access funding enabled and organized by Projekt DEAL., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Ultrasound-assisted multicomponent synthesis of 4H-pyrans in water and DNA binding studies

  • Auria-Luna, Fernando
  • Fernández-Moreira, Vanesa
  • Marqués-López, Eugenia
  • Gimeno, M. Concepción
  • Herrera, Raquel P.
A simple approach to synthesize new highly substituted 4H-pyran derivatives is described. Efficient Et3N acts as a readily accessible catalyst of this process performed in pure water and with only a 20 mol% of catalyst loading. The extremely simple operational methodology, short reaction times, clean procedure and excellent product yields render this new approach extremely appealing for the synthesis of 4H-pyrans, as potentially biological scaffolds. Additionally, DNA interaction analysis reveals that 4H-pyran derivatives behave preferably as minor groove binders over major groove or intercalators. Therefore, this is one of the scarce examples where pyrans have resulted to be interesting DNA binders with high binding constants (Kb ranges from 1.53 × 104 M−1 to 2.05 × 106 M−1)., This work was supported by a 2018 Leonardo Grant for Researchers and Cultural Creators, BBVA Foundation. The authors also thank Ministerio de Economía, Industria y Competitividad (MINECO-FEDER CTQ2016-75816-C2-1-P, CTQ2017-88091-P, PID2019-104379RB-C21, RTI2018-097836-J-I00, RED2018-102471-T and RYC2018-025872-I) and Gobierno de Aragón-Fondo Social Europeo (Research Group E07_20R) for financial support of our research., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Coordination polymers nanoparticles for bioimaging

  • Suárez-García, Salvio
  • Solorzano, Rubén
  • Novio, Fernando
  • Alibés, Ramón
  • Busqué, Félix
  • Ruiz Molina, Daniel
Early diagnosis of patient diseases is subjected to the appropriate use of bioimaging techniques. For this reason, the development of contrast agents that improve and enhance the response of current clinical imaging practices is a pressing concern. Non-invasive bioimaging techniques most often need specific probes to follow and measure biological routes in living systems. These molecular imaging agents must exhibit: I) a remarkable contrast effect, i.e. a high signal-to-noise ratio under real physiological conditions, II) pronounced in vivo stability under the effect of numerous enzymes or proteases present in serum or targeted tissue equilibrated with a fast clearance from healthy organs and III) low cost and eco-friendly production. To overcome current drawbacks that hindrance the full development of the different bioimaging techniques, several groups are exploring nanoparticles as contrast agents. In this scenario, coordination polymer nanoparticles have emerged as a handy platform offering predesigned unique advantages thanks to their chemical flexibility, structural diversity and tailoring skills. Indeed, these systems reveal high metal cargos, low toxicity and multifunctional character by adequately selecting the combination of metal ions and ligands. Moreover, in a reminiscent way of organic polymeric nanoparticles, coordination polymer nanoparticles have also demonstrated its ability to encapsulate therapeutic-active molecules, thus combining diagnostic and therapeutic functionalities, the so-called Theranostic nanomedicine. For all these reasons, the use of this family of nanoparticles as imaging contrast agents has attracted broad interest over the last years with numerous examples being reported. Herein, we review main accomplishments in the area grouped according to the used technology, including magnetic resonance imaging, computed tomography, optical imaging, radioimaging or photoacoustic imaging., This work was supported by grants RTI2018-098027-B-C21, CTQ2016-75363-R and RED2018-102471-T from the Spanish Government funds and by the European Regional Development Fund (ERDF). The ICN2 is funded by the CERCA programme/Generalitat de Catalunya. The ICN2 is supported by the Severo Ochoa Centres of Excellence programme, funded by the Spanish Research Agency (AEI, grant no. SEV-2017-0706). R. S. thanks the Ministerio de Educación, Cultura y Deporte for the predoctoral grant FPU14/03170. S.S.-G. acknowledges the support from MINECO BES-2015-071492 grant., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Theranostics through the synergistic cooperation of heterometallic complexes

  • Redrado, Marta
  • Fernández-Moreira, Vanesa
  • Gimeno, M. Concepción
Heterometallic drugs are emerging as a great alternative to conventional metallodrugs. Careful selection of different metallic fragments makes possible to enhance not only the therapeutic potential by a synergistic effect, but also to incorpore key features like traceability. Drugs that integrate traceability and therapy in one system are known as theranostic agents. In cancer research, theranostic agents are becoming increasingly important. They deliver crucial information regarding their biological interplay that can ultimately be used for optimization. The well‐established therapeutic potential of PtII‐, RuII‐ and AuI‐based drugs combined with the outstanding optical properties of d6 transition metal complexes grant the delivery of traceable metallodrugs. These species can be easily fine‐tuned through modification of their respective ligands to provide a new generation of drugs., The authors thank the AEI (Ministerio de Ciencia Innovación y Universidades) for projects PID2019‐104379RB−C21, RTI2018‐097836‐J−I00, RYC2018‐025872 and RED2018‐102471‐T, and Gobierno de Aragón‐Fondo Social Europeo (E07_20R) for financial support. M.R. thanks the Gobierno de Aragón for a predoctoral fellowship., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Fully supercritical CO2 preparation of a nanostructured MOF composite with application in cutaneous drug delivery

  • Kubovics, Márta
  • Rojas, Sara
  • López Periago, Ana M.
  • Fraile, Julio
  • Horcajada, Patricia
  • Domingo Pascual, M. Concepción
Supercritical CO2 (scCO2) technology is used here as an efficient method to assist in the preparation of a cutaneous polymeric formulation based on drug containing metal-organic framework composites. The supercritical fluid is used in three steps: (i) as a drying agent for the nanosized mesoporous matrix, (ii) as the impregnation vector of a topical antibiotic drug, and (iii) as a plasticizing and foaming fluid to obtain dispersions of the hybrid material into a biocompatible polymer, e.g., the macroporous patch. The materials were characterized using solid state techniques. The drug delivery and permeation profiles of the patches were investigated applying in vitro and ex vivo tests by using porcine skin. These analyses suggest that scCO2 impregnation is an easy and fast strategy to prepare composite devices able to progressively release and diffuse the incorporated drug throughout the skin, paving the way to efficiently prepare cutaneous devices for topical or systemic therapies., This work was supported by the Spanish Ministry of Science and Innovation MICINN through the Severo Ochoa Program for Centers of Excellence (CEX2019–000917-S) and the Spanish National Plan of Research with projects CTQ2017–83632 and PID2020–115631GB-I00 (Concepción Domingo, Ana M. López and Márta Kubovics). Sara Rojas and Patricia Horcajada acknowledge the regional Madrid founding (Talento 2017 Modality 2, 2017-T2/IND-5149), the MOFSEIDON project (PID2019–104228RB-I00, MCI/AEI/FEDER, UE), and the Multifunctional Metallodrugs in Diagnosis and Therapy Network (MICIU, RED2018–102471-T). Márta Kubovics acknowledge the financial support from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie Cofund grant (agreement no MSCA-COFUND-DP/0320–754397). Patricia Horcajada acknowledges the Spanish Ramon y Cajal Programme (grant agreement no. 2014–16823). Sara Rojas acknowledges the Spanish Juan de la Cierva Incorporación Fellowship (grant agreement no. IJC2019–038894-I). This work has been done in the framework of the doctoral program “Chemistry” of the Universitat Autònoma de Barcelona by Márta Kubovics., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Multifunctional heterometallic IrIII−AuI probes as promising anticancer and antiangiogenic agents

  • Redrado, Marta
  • Benedi, Andrea
  • Marzo, Isabel
  • García-Otín, Angel L.
  • Fernández-Moreira, Vanesa
  • Gimeno, M. Concepción
A new class of emissive cyclometallated IrIII−AuI complexes with a bis(diphenylphosphino) methanide bridging ligand was successfully synthesised from the diphosphino complex [Ir(N^C)2(dppm)]+ (1). The different gold ancillary ligand, a triphenylphosphine (2), a chloride (3) or a thiocytosine (4) did not reveal any significant effect on the photophysical properties, which are mainly due to metal-to-ligand charge-transfer (3MLCT) transitions based on IrIII. However, the AuI fragment, along with the ancillary ligand, seemed crucial for the bioactivity in A549 lung carcinoma cells versus endothelial cells. Both cell types display variable sensitivities to the complexes (IC50=0.6–3.5 μM). The apoptotic pathway is activated in all cases, and paraptotic cell death seems to take place at initial stages in A549 cells. Species 2–4 showed at least dual lysosomal and mitochondrial biodistribution in A549 cells, with an initial lysosomal localisation and a possible trafficking process between both organelles with time. The bimetallic IrIII−AuI complexes disrupted the mitochondrial transmembrane potential in A549 cells and increased reactive oxygen species (ROS) generation and thioredoxin reductase (TrxR) inhibition in comparison with that displayed by the monometallic complex 1. Angiogenic activity assays performed in endothelial cells revealed the promising antimetastatic potential of 1, 2 and 4., Authors thank the Agencia Estatal de Investigación (projects PID2019-104379RB−C21, RTI2018-097836-J−I00, RYC2018-025872-I and RED2018-102471-T), Instituto de Salud Carlos III (PI16/02112), and Gobierno de Aragón-Fondo Social Europeo (E07_20R, B04_20R) for financial support. M.R.D thanks the Gobierno de Aragón for a predoctoral fellowship., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Synthesis of new thiourea-metal complexes with promising anticancer properties

  • Canudo-Barreras, Guillermo
  • Ortego, Lourdes
  • Izaga, Anabel
  • Marzo, Isabel
  • Herrera, Raquel P.
  • Gimeno, M. Concepción
This article belongs to the Special Issue Metal-Based Drugs: Bioinorganic Chemistry and Modes of Action—Dedicated to the Research Activity of Professor Luigi Messori., In this work, two thiourea ligands bearing a phosphine group in one arm and in the other a phenyl group (T2) or 3,5-di-CF3 substituted phenyl ring (T1) have been prepared and their coordination to Au and Ag has been studied. A different behavior is observed for gold complexes, a linear geometry with coordination only to the phosphorus atom or an equilibrium between the linear and three-coordinated species is present, whereas for silver complexes the coordination of the ligand as P^S chelate is found. The thiourea ligands and their complexes were explored against different cancer cell lines (HeLa, A549, and Jurkat). The thiourea ligands do not exhibit relevant cytotoxicity in the tested cell lines and the coordination of a metal triggers excellent cytotoxic values in all cases. In general, data showed that gold complexes are more cytotoxic than the silver compounds with T1, in particular the complexes [AuT1(PPh3)]OTf, the bis(thiourea) [Au(T1)2]OTf and the gold-thiolate species [Au(SR)T1]. In contrast, with T2 better results are obtained with silver species [AgT1(PPh3)]OTf and the [Ag(T1)2]OTf. The role played by the ancillary ligand bound to the metal is important since it strongly affects the cytotoxic activity, being the bis(thiourea) complex the most active species. This study demonstrates that metal complexes derived from thiourea can be biologically active and these compounds are promising leads for further development as potential anticancer agents., This research was funded by Agencia Estatal de Investigación (AEI), projects CTQ2017-88091-P (AEI/FEDER, UE), PID2019-104379RB-C21 and PID2020-117455GB-I00/AEI/10.13039/501100011033; RED2018-102471-T (MCIN/AEI/10.13039/501100011033) and Gobierno de Aragón-Fondo Social Europeo (Research Group E07_20R)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Cytotoxic activity and G-quadruplex stabilization of Ir(III) complexes with phenanthroimidazole derivative ligands

  • Fidalgo, Jairo
  • Santolaya, Javier
  • Fernández-Moreira, Vanesa
  • Gimeno, M. Concepción
  • Busto, Natalia
  • García González, María Begoña
  • Espino, Gustavo
Resumen del póster presentado a la 24th Virtual Conference on Organometallic Chemistry (EuCOMC XXIV Virtual Conference), celebrada del 1 al 3 de septiembre de 2021., Metal complexes are playing an important role over the last few years in the design of new fluorophores with potential application in cell imaging and cancer therapy. Focusing on DNA as the cellular target, G-quadruplex DNA-forming sequences have attracted great attention because they are involved in several biological processes, from chromosome protection to senescence process. In fact, the higher prevalence of these structures in cancer cells than in normal cells, link G4 structures with cancer. So a growing interest is devoted to drugs with a good affinity for G4-DNA and selectivity towards G-quadruplex over duplex DNA to enhance and/or promote quadruplex-related biological effects., Bearing in mind the above-mentioned, we have synthesized a couple of Ir(III) biscyclometallated phosphorescent complexes, [Ir1]Cl and [Ir2]Cl, which incorporate two different imidazolephenanthroline ligands, L1 and L2, where L1 holds an acidic N-H group, while L2 is decorated with a N-Ph group. As shown in this work, such a trivial functional change influences the acidbase and redox chemistry of [Ir1]Cl and [Ir2]Cl, and what is more interesting, it also affects the subcellular localization of these derivatives, their cytotoxic behaviour and their mechanism of action. Finally, both complexes are able to stabilize a battery of G4 structures with preference for antiparallel two-tetrads G4 (Bom17 and TBA). In addition, [Ir1]Cl exhibits selectivity for G-quadruplex even in the presence of a DNA double helix as competitor revealing the potential of this complex for specifically target G4 structures., The authors thank “La Caixa” Foundation (LCF/PR/PR12/11070003), Junta de Castilla y León (BU305P18, FEDER Funds and ORDEN EDU/574/2018) and ministerio de Ciencia, Innovación y Universidades (RTI2018- 100709-B-C21 , RTI2018-102040-B-100 and RED2018-102471-T). Networking support by COST Action CA18202 (NECTAR) is also acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Piano-stool ruthenium(II) complexes with delayed cytotoxic activity: Origin of the lag time

  • Rafols, Laia
  • Josa, Dana
  • Aguilà, David
  • Barrios, Leoní A.
  • Roubeau, Olivier
  • Cirera, Jordi
  • Soto-Cerrato, Vanessa
  • Pérez-Tomás, Ricardo
  • Martínez, Manuel
  • Grabulosa, Arnald
  • Gamez, Patrick
We have recently reported a series of piano-stool ruthenium(II) complexes of the general formula [RuCl2(η6-arene)(P(1-pyrenyl)R2R3)] showing excellent cytotoxic activities (particularly when R2 = R3 = methyl). In the present study, new members of this family of compounds have been prepared with the objective to investigate the effect of the steric hindrance of a bulky phosphane ligand, namely diisopropyl(1-pyrenyl)phosphane (L), on exchange reactions involving the coordinated halides (X = Cl, I). Two η6-arene rings were used, i.e. η6-methyl benzoate (mba) and η6-p-cymene (p-cym), and four complexes were synthesized, namely [RuCl2(mba)(L)] (1Cl2iPr), [RuI2(mba)(L)] (1I2iPr), [RuCl2(p-cym)(L)] (2Cl2iPr), and [RuI2(p-cym)(L)] (2I2iPr). Unexpectedly, all of the complexes exhibited poor cytotoxic activities after 24 h of incubation with cells, in contrast to the related compounds previously reported. However, it was observed that aged DMSO solutions of 2I2iPr (from 2 to 7 days) exhibited better activities in comparison to freshly prepared solutions and that the activity improved over “aging” time. Thorough studies were therefore performed to uncover the origin of this lag time in the cytotoxicity efficiency. The data achieved clearly demonstrated that compounds 2I2iPr and 2Cl2iPr were undergoing a series of transformation reactions in DMSO (with higher rates for the iodido complex 2I2iPr), ultimately generating cyclometalated species through a mechanism involving DMSO as a coordinated proton abstractor. The cyclometalated complexes detected in solution were subsequently prepared; hence, pure [RuCl(p-cym)(κ2C-diisopropyl(1-pyrenyl)phosphane)] (3CliPr), [RuI(p-cym)(κ2C-diisopropyl(1-pyrenyl)phosphane)] (3IiPr), and [Ru(p-cym)(κS-dmso)(κ2C-diisopropyl(1-pyrenyl)phosphane)]PF6 (3dmsoiPr) were synthesized and fully characterized. Remarkably, 3CliPr, 3IiPr, and 3dmsoiPr are all very efficient cytotoxic agents, exhibiting slightly better activities in comparison to the chlorido noncyclometalated complexes [RuCl2(η6-arene)(P(1-pyrenyl)R2R3)] described in an earlier report. For comparison purposes, the iodido compounds [RuI2(mba)(dimethyl(1-pyrenyl)phosphane)] (1I2Me) and [RuI2(p-cym)(dimethyl(1-pyrenyl)phosphane)] (2I2Me), bearing the less hindered dimethyl(1-pyrenyl)phosphane ligand, have also been prepared. The cytotoxic and chemical behaviors of 1I2Me and 1I2Me were comparable to those of their chlorido counterparts reported previously., Financial support from the Spanish Ministerio de Ciencia Innovación, y Universidades (Project Nos. CTQ2015-65040-P, RED2018-102471-T, PID2019-107006GB-C21, PGC2018-098630-B-I00, and CTQ2017-88446-R AEI/FEDER, UE) and from the Instituto de Salud Carlos III (ISCIIIFIS PI18/00441, FEDER) is acknowledged. A.G. thanks the Royal Society of Chemistry for financial support (RSC Research Fund grant RF19-7147). J.C. thanks the Spanish MICINN for a Ramoń y Cajal research contract (RYC2018-024692-I) and the Spanish Structures of Excellence María de Maeztu program (MDM-2017-0767). P.G. acknowledges the Institució Catalana de Recerca i Estudis Avançats (ICREA)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Sulfonamide‐derived dithiocarbamate gold(I) complexes Induce the apoptosis of colon cancer cells by the activation of caspase 3 and redox imbalance

  • Quero, Javier
  • Royo, José Carlos
  • Fodor, Beatrice
  • Gimeno, M. Concepción
  • Osada, Jesús
  • Rodríguez-Yoldi, María Jesús
  • Cerrada, Elena
This article belongs to the Special Issue Gold and Silver Complexes in the Treatment of Diseases., Two new families of dithiocarbamate gold(I) complexes derived from benzenesulfonamide with phosphine or carbene as ancillary ligands have been synthesized and characterized. In the screening of their in vitro activity on human colon carcinoma cells (Caco-2), we found that the more lipophilic complexes—those with the phosphine PPh3—exhibited the highest anticancer activity whilst also displaying significant cancer cell selectivity. [Au(S2CNHSO2C6H5)(PPh3)] (1) and [Au(S2CNHSO2-p-Me-C6H4)(IMePropargyl)] (8) produce cell death, probably by intrinsic apoptosis (mitochondrial membrane potential modification) and caspase 3 activation, causing cell cycle arrest in the G1 phase with p53 activation. Besides this, both complexes might act as multi-target anticancer drugs, as they inhibit the activity of the enzymes thioredoxin reductase (TrxR) and carbonic anhydrase (CA IX) with the alteration of the redox balance, and show a pro-oxidant effect., This work was financed by MCIN-Agencia Estatal de Investigación Grants PID2019-104379RB-C21/AEI/10.13039/501100011033 and PID2019-104915RBI00, CIBEROBN (CB06/03/1012), Red Multimetdrugs (RED2018-102471-T/MCIN/AEI/10.13039/501100011033) and Gobierno de Aragón (B16_20R and E07_20R, Fondos FEDER “otra manera de hacer Europa”)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Monocolor chemosensors for Ba2+ tagging experiments

  • Molina-Canteras, Juan
  • Auria-Luna, Fernando
  • Aparicio, Borja
  • Larumbe, Amaia
  • Herrero-Gómez, P.
  • Rogero, Celia
  • Odriozola-Gimeno, Mikel
  • Aranburu, Ane I.
  • Valle, Pablo R.G.
  • Freixa, Zoraida
  • Monrabal, Francesc
  • Gómez Cadenas, Juan José
  • Rivilla, Iván
  • Cossío, Fernando P.
Resumen del póster presentado a la XXXVIII Reunión Bienal de la Real Sociedad Española de Química, celebrada en el Palacio de Congresos de Granada, del 27 de junio al 30 de junio de 2022., The BOLD experiment is focused on the observation of the neutrinoless double β decay of 136Xe to 136Ba2+ through the detection of the daughter cation. For this purpose, different molecular sensors can be developed. These chemosensors can be classified into monocolor (offon) or bicolor (on-on’), depending on the shifts (Δλ) and changes in the intensity (ΔI) observed in their emission spectra. In this context, different off-on radiometric chemosensors have been synthesized in order to understand their photophysics upon interaction with Ba2+ ions in vacuo and in solution. These sensors incorporate two components: a fluorophore and a metal-binding group. The fluorophores are kept as simple as possible, using structures with well-known photophysical properties. On the other hand, N-aza-crown ether derivatives have been used as metal-binding groups. Finally, the effects of disconnecting the abovementioned elements by splitting of components Ar1 and Ar2 (Figure 1: Description of the off-on chemosensors synthesized in this work), will be discussed., Financial support from the Basque Government (IT-1346-19 and IT-1180-19), the Spanish MICINN (PID2019-104772-GB-I00, PID2019-111281-GB-I00, RED2018-102387-T, and RED2018-102471-T), and by the European Commission (ERC-2020-SyG-951281) is gratefully acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

New generation of fluorescent bicolour sensors for barium tagging experiments

  • Auria-Luna, Fernando
  • Molina-Canteras, Juan
  • Aparicio, Borja
  • Larumbe, Amaia
  • Herrero-Gómez, P.
  • Rogero, Celia
  • Odriozola-Gimeno, Mikel
  • Aranburu, Ane I.
  • Valle, Pablo R.G.
  • Freixa, Zoraida
  • Monrabal, Francesc
  • Gómez Cadenas, Juan José
  • Rivilla, Iván
  • Cossío, Fernando P.
Resumen del póster presentado a la XXXVIII Reunión Bienal de la Real Sociedad Española de Química, celebrada en el Palacio de Congresos de Granada, del 27 de junio al 30 de junio de 2022., One of the most important questions in particle physics and cosmology consists of demonstrating that the neutrino is a Majorana fermion. Observation of the neutrinoless double β decay of 136Xe to generate the daughter cation 136Ba2+ is the most promising practical way to demonstrate this hypothesis. Within this context, our research group has designed and synthesized the first generation of fluorescent bicolour sensors (FBI-G1), whose emission spectra change upon binding to Ba2+ ions by formation of supramolecular complexes in dry media involving solid-gas interphases. In this presentation, the synthesis of a second generation (G2) of bicolour sensors is reported. These sensors have two essential components, a metal-binding group, and a fluorophore. The latest structure is based on a benzo[a]imidazo[2,1,5-cd]indolizine derivative (Figure 1: Description of generation 1 (left) and generation 2 (right) chemosensors). Finally, preliminary research involving the linkage of our sensors to surfaces such as indium tin oxide glass (ITO), will be discussed., Financial support from the Basque Government (IT-1346-19 and IT-1180-19), the Spanish MICINN (PID2019-104772-GB-I00, PID2019-111281-GB-I00, RED2018-102387-T, and RED2018-102471-T), and by the European Commission (ERC-2020-SyG-951281) is gratefully acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Iridium-based sensor for cations

  • Aranburu, Ane I.
  • Auria-Luna, Fernando
  • Molina-Canteras, Juan
  • Aparicio, Borja
  • Larumbe, Amaia
  • Herrero-Gómez, P.
  • Rogero, Celia
  • Odriozola-Gimeno, Mikel
  • Valle, Pablo R.G.
  • Monrabal, Francesc
  • Gómez Cadenas, Juan José
  • Rivilla, Iván
  • Cossío, Fernando P.
  • Freixa, Zoraida
Resumen del póster presentado a la XXXVIII Reunión Bienal de la Real Sociedad Española de Química, celebrada en el Palacio de Congresos de Granada, del 27 de junio al 30 de junio de 2022., Traditionally, techniques such as inductively coupled plasma mass spectroscopy or gas chromatography have been used for cation detection. However, these methods need long analysis times and sophisticated instrumentation. Simpler and faster methods have been developed these days, such us optical methods (colorimetric and/or fluorescent), which can entail easy visualization, high sensitivity and cheaper instrumentation. Among these, ratiometric (bicolour) fluorescent sensors stand out due to the lower limit of detection. In this area, both organic molecules and metal complexes are being developed as luminescent probes. Indeed, some iridium complexes demonstrated to be selective luminescent sensors for different cations. Different strategies are used to trap or interact with the cation, which permits a rational tuning of the iridium’s emission. In our group, we have been working with iridium complexes for a variety of objectives. In this contribution, an iridium-based sensor for cations will be described including its response to cations in solution and on solid supports., Financial support from the Basque Government (PRE_2020_2_0230, IT-1346-19 and IT-1180-19), the Spanish MICINN (PID2019-104772-GB-I00, PID2019-111281-GB-I00, RED2018-102387-T, and RED2018-102471-T), and by the European Commission (ERC-2020-SyG-951281) is gratefully acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Advances in Preclinical/Clinical Glioblastoma Treatment: Can Nanoparticles Be of Help?

  • Ruiz Molina, Daniel
  • Mao, Xiaoman
  • Alfonso Triguero, Paula
  • Lorenzo, Julia
  • Bruna, Jordi
  • Yuste, Víctor J.
  • Candiota, Ana Paula
  • Novio, Fernando
Glioblastoma multiforme (GB) is the most aggressive and frequent primary malignant tumor in the central nervous system (CNS), with unsatisfactory and challenging treatment nowadays. Current standard of care includes surgical resection followed by chemotherapy and radiotherapy. However, these treatments do not much improve the overall survival of GB patients, which is still below two years (the 5-year survival rate is below 7%). Despite various approaches having been followed to increase the release of anticancer drugs into the brain, few of them demonstrated a significant success, as the blood brain barrier (BBB) still restricts its uptake, thus limiting the therapeutic options. Therefore, enormous efforts are being devoted to the development of novel nanomedicines with the ability to cross the BBB and specifically target the cancer cells. In this context, the use of nanoparticles represents a promising non-invasive route, allowing to evade BBB and reducing systemic concentration of drugs and, hence, side effects. In this review, we revise with a critical view the different families of nanoparticles and approaches followed so far with this aim., This work was supported by grant RTI2018-098027-B-C21, RTI2018-098027-B-C22, and PID2020-113058GB-I00 funded by MCIN/AEI/10.13039/501100011033, by ERDF A way of making Europe and by PI21/00181 from the Instituto Carlos III. This work was also supported by “Metalfármacos multifuncionales para el diagnóstico y la terapia”, through grant RED2018-102471-T, funded by MCIN/AEI/10.13039/501100011033. The ICN2 and IDIBELL are funded by the CERCA programme/Generalitat de Catalunya. The ICN2 is supported by the Severo Ochoa Centres of Excellence programme, grant SEV-2017-0706, funded by MCIN/AEI/10.13039/501100011033. COST is kindly acknowledged for stimulating scientific discussion and financial support via the Cost Action CA 17140 “Cancer nanomedicine from the bench to the bedside”. A.P.C. received funding from the ATTRACT project funded by the EC under Grant Agreement 777222. This work was also supported by the Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN [http://www.ciber-bbn.es/en], CB06/01/0010), an initiative of the Instituto de Salud Carlos III (Spain). The PhD program of X.M. was supported by the La Caixa-Severo Ochoa International PhD Fellowship.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Intranasal Administration of Catechol-Based Pt(IV) Coordination Polymer Nanoparticles for Glioblastoma Therapy

  • Mao, Xiaoman
  • Calero Pérez, Pilar
  • Montpeyó, David
  • Bruna, Jordi
  • Yuste, Víctor J.
  • Candiota, Ana Paula
  • Lorenzo, Julia
  • Novio, Fernando
  • Ruiz Molina, Daniel
Cisplatin has been described as a potent anticancer agent for decades. However, in the case of glioblastomas, it is only considered a rescue treatment applied after the failure of second-line treatments. Herein, based on the versatility offered by coordination chemistry, we engineered nanoparticles by reaction of a platinum (IV) prodrug and iron metal ions showing in vitro dual pH-and redox-sensitivity, controlled release and comparable cytotoxicity to cisplatin against HeLa and GL261 cells. In vivo intranasal administration in orthotopic preclinical GL261 glioblastoma tumor-bearing mice demonstrated increased accumulation of platinum in tumors, leading in some cases to complete cure and prolonged survival of the tested cohort. This was corroborated by a magnetic resonance imaging follow-up, thus opening new opportunities for intranasal glioblastoma therapies while minimizing side effects. The findings derived from this research showed the potentiality of this approach as a novel therapy for glioblastoma treatment., This work was supported by grant RTI2018-098027-B-C21, RTI2018-098027-B-C22 and PID2020-113058GB-I00 funded by MCIN/AEI/10.13039/501100011033 and by ERDF A way of making Europe. With the support from “Metalfármacos multifuncionales para el diagnóstico y la terapia” with grant RED2018-102471-T funded by MCIN/AEI/10.13039/501100011033. The ICN2 is funded by the CERCA programme/Generalitat de Catalunya. The ICN2 is supported by the Severo Ochoa Centres of Excellence programme, grant SEV-2017-0706 funded by MCIN/AEI/10.13039/501100011033. COST is kindly acknowledged for stimulating scientific discussion and financial support via the Cost Action CA 17140 “Cancer nanomedicine from the bench to the bedside”. A.P.C. received funding from the ATTRACT project funded by the EC under Grant Agreement 777222. Work also supported by Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN [http://www.ciber-bbn.es/en, accessed on 24 March 2022], CB06/01/0010), an initiative of the Instituto de Salud Carlos III (Spain). The PhD program of X.M. was supported by the La Caixa-Severo Ochoa International PhD Fellowship. We acknowledge the UAB Predoctoral training program (14ª Convocatoria PIF-19612, predoctoral fellowships for P.C.-P)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Synthesis and Validation of a Bioinspired Catechol-Functionalized Pt(IV) Prodrug for Preclinical Intranasal Glioblastoma Treatment

  • Mao, Xiaoman
  • Wu, Shuang
  • Calero Pérez, Pilar
  • Candiota, Ana Paula
  • Alfonso Triguero, Paula
  • Bruna, Jordi
  • Yuste, Víctor J.
  • Lorenzo, Julia
  • Novio, Fernando
  • Ruiz Molina, Daniel
Glioblastoma is the most malignant and frequently occurring type of brain tumors in adults. Its treatment has been greatly hampered by the difficulty to achieve effective therapeutic concentration in the tumor sites due to its location and the blood–brain barrier. Intranasal administration has emerged as an alternative for drug delivery into the brain though mucopenetration, and rapid mucociliary clearance still remains an issue to be solved before its implementation. To address these issues, based on the intriguing properties of proteins secreted by mussels, polyphenol and catechol functionalization has already been used to promote mucopenetration, intranasal delivery and transport across the blood–brain barrier. Thus, herein we report the synthesis and study of complex 1, a Pt(IV) prodrug functionalized with catecholic moieties. This complex considerably augmented solubility in contrast to cisplatin and showed a comparable cytotoxic effect on cisplatin in HeLa, 1Br3G and GL261 cells. Furthermore, preclinical in vivo therapy using the intranasal administration route suggested that it can reach the brain and inhibit the growth of orthotopic GL261 glioblastoma. These results open new opportunities for catechol-bearing anticancer prodrugs in the treatment for brain tumors via intranasal administration., This work was supported by grant RTI2018-098027-B-C21, RTI2018-098027-B-C22 and PID2020-113058GB-I00 funded by MCIN/AEI/10.13039/501100011033 and by ERDF’s A way of making Europe as well as with the support from “Metalfármacos multifuncionales para el diagnóstico y la terapia” with grant RED2018-102471-T funded by MCIN/AEI/10.13039/501100011033. The ICN2 is funded by the CERCA programme/Generalitat de Catalunya. The ICN2 is supported by the Severo Ochoa Centres of Excellence programme, and grant SEV-2017-0706 is funded by MCIN/AEI/10.13039/501100011033. COST is kindly acknowledged for stimulating scientific discussion and financial support via the Cost Action CA 17140 “Cancer nanomedicine from the bench to the bedside”. A.P.C. received funding from the ATTRACT project funded by the EC under grant agreement 777222. The work was also supported by Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN [http://www.ciber-bbn.es/en, accessed on 24 November 2021], CB06/01/0010), an initiative of the Instituto de Salud Carlos III (Spain). The PhD program of X.M. was supported by the La Caixa-Severo Ochoa International PhD Fellowship. We acknowledge the UAB predoctoral training program (14th Convocatoria PIF-19612, predoctoral fellowships for P.C.-P) and China Scholarship Council (predoctoral fellowship 201606990027 for S.W.).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Synthesis and antiproliferative study of phosphorescent multimetallic Re(I)/Au(I) complexes containing fused imidazo[4,5-f]-1,10-phenanthroline core

  • Luengo, Andrés
  • Marzo, Isabel
  • Fernández-Moreira, Vanesa
  • Gimeno, M. Concepción
Five heterobimetallic ReI/AuI and a tri-metallic ReI/AuI/ReI species following the formulas fac-[ReCl (CO)3(N^N^CAuR)]0/+ and [(fac-[ReCl (CO)3(N^N^C)])2Au]+, where R is an iodide (1), phenylacetylene (2), dodecanethiol (3), 2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranose (4) and JohnPhos (5) and N^N^C is the fused imidazo[4,5-f]-1,10-phenanthroline heterotopic ligand, were synthesised and fully characterised by a variety of spectroscopic and analytical techniques. The resultant complexes are luminescent in the orange region, revealing classical metal-to-ligand charge transfer (3MLCT) ((Re (dπ) → (N^N^C)(π*)) emission in aerated DMSO solution. The red shifted emission observed on going from 3 to 4 suggests that the electronic properties of the gold ancillary ligand are implicated in the emissive properties. Antiproliferative activity in tumour cell lines, lung (A549) and cervix (HeLa) cells revealed that only complex 4 containing a 2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranose as gold ancillary ligand possesses certain cytotoxicity in both cell lines., Authors thank the Agencia Estatal de Investigación, projects PID2019-104379RB-C21/AEI /10.13039/501100011033, RTI2018-097836-J-I00/MCIN/AEI/10.13039/501100011033/FEDER, RYC2018-025872-I (funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”), RED2018-102471-T/MCIN/AEI/10.13039/501100011033, and Gobierno de Aragón-Fondo Social Europeo (E07_20R) for financial support. A.L. thanks the Gobierno de Aragón for a predoctoral fellowship., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Synthesis of dipyridylaminoperylenediimide–metal complexes and their cytotoxicity studies

  • Garcés-Garcés, Jose
  • Redrado, Marta
  • Sastre-Santos, Ángela
  • Gimeno, M. Concepción
  • Fernández-Lázaro, Fernando
This article belongs to the Special Issue Engineering and Characterisation of Novel Nanomedicine Formulations., A new family of perylenediimide (PDI) silver and copper complexes has been successfully synthesized by reacting ortho- and bay-substituted (dipyrid-2′,2″-ylamino)perylenediimide ligands with metal phosphine fragments. The coordination of the metal center did not reveal a significant effect on the photophysical properties, which are mainly due to the PDI ligands, and in some cases quenching of the luminescence was observed. The antiproliferative effect of the free perylenediimide ligands and the metalloPDI complexes against the cervix cancer cell line HeLa was determined by MTT assay. The free perylenediimide ligands exhibited a moderate cytotoxic activity, but the coordination of silver or copper to the dypyridylamino fragment greatly enhanced the activity, suggesting a synergistic effect between the two fragments. In attempts to elucidate the cellular biodistribution of the PDIs and the complexes, a colocalization experiment using specific dyes for the lysosomes or mitochondria as internal standards revealed a major internalization inside the cell for the metal complexes, as well as a partial mitochondrial localization., This research was funded by Agencia Estatal de Investigación (AEI), projects PID2019-109200GB-I00, PID2019-104379RB-C21/AEI/10.13039/501100011033, RED2018-102471-T (MCIN/AEI /10.13039/501100011033) and Gobierno de Aragón-Fondo Social Europeo (Research Group E07_20R)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Tunable emissive Ir(III) benzimidazole-quinoline hybrids as promising theranostic lead compounds

  • Redrado, Marta
  • Miñana, Miriam
  • Coogan, Michael P.
  • Gimeno, M. Concepción
Bioactive and luminescent cyclometallated Ir(III) complexes [Ir(ppy)2L1]Cl (1) and [Ir(ppy)2L2]Cl (2) containing a benzimidazole derivative (L1/L2) as auxiliary mimic of a nucleotide have been synthesised. The emissive properties of both complexes are conditioned by the nature of L1 and L2, rendering an orange and a green emitter respectively. Both are highly emissive with quantum yield increasing in absence of oxygen up to 0.26 (1) and 0.36 (2), suggesting their phosphorescent character. Antiproliferative activity against lung cancer A549 cells increased up to 15 times upon irradiation conditions, reaching IC50 values in the nanomolar range (0.3±0.09 μM (1) and 0.26±0.14 μM (2)) and pointing them as good PSs candidates for photodynamic therapy via 1O2 generation. Cellular biodistribution analysis by fluorescence microscopy suggest the lysosomes as the preferential accumulation organelle. Time-resolved studies showed a greatly increased cellular emission lifetime compared to the solution values, indicating binding to macromolecules or cellular structures and restriction of collision and vibrational quenching., Authors thank the Agencia Estatal de Investigación, projects PID2019-104379RB-C21/AEI/10.13039/501100011033, RTI2018-097836-J-I00/MCIN/AEI/10.13039/501100011033/FEDER, RYC2018-025872-I (funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”), RED2018-102471-T/MCIN/AEI/10.13039/501100011033, and Gobierno de Aragón-Fondo Social Europeo (E07_20R) for financial support. M. R. thanks the Gobierno de Aragón for a predoctoral fellowship., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Flavin-conjugated Pt(IV) anticancer agents

  • Sánchez-Camacho, Juan
  • Infante-Tadeo, Sonia
  • Carrasco, Ana C.
  • Scoditti, Stefano
  • Martínez, Álvaro
  • Barroso-Bujans, Fabienne
  • Sicilia, Emilia
  • Pizarro, Ana M.
  • Salassa, Luca
In situ activation of Pt(IV) to Pt(II) species is a promising strategy to control the anticancer activity and overcome the off-target toxicity linked to classic platinum chemotherapeutic agents. Herein, we present the design and synthesis of two new asymmetric Pt(IV) derivatives of cisplatin and oxaliplatin (1·TARF and 2·TARF, respectively) bearing a covalently bonded 2′,3′,4′,5′-tetraacetylriboflavin moiety (TARF). 1H and 195Pt NMR spectroscopy shows that 1·TARF and 2·TARF can be effectively activated into toxic Pt(II) species, when incubated with nicotinamide adenine dinucleotide, sodium ascorbate, and glutathione in the dark and under light irradiation. Density functional theory studies of the dark Pt(IV)-to-Pt(II) conversion of 2·TARF indicate that the process involves first hydride transfer from the donor to the flavin moiety of the complex, followed by electron transfer to the Pt(IV) center. When administered to MDA-MB-231 breast cancer cells preincubated with nontoxic amounts of ascorbate, 2·TARF displays enhanced toxicity (between 1 and 2 orders of magnitude), suggesting that the generation of oxaliplatin can selectively be triggered by redox activation. Such an effect is not observed when 2 and TARF are coadministered under the same conditions, demonstrating that covalent binding of the flavin to the Pt complex is pivotal., We acknowledge financial support from the Spanish State Research Agency (Grants PID2019-109111RB-I00, RED2018-102471-T, FJC2021-047527-I, PRE2020-093560, and PID2020-117766GBI00), the Basque Government (Eusko Jaurlaritza Grants IT1254-19 and PIBA_2021_1_0034), the Diputación Foral de Gipuzkoa (RED 2021), and the Comunidad Autónoma de Madrid (Scholarship PEJD-2016/IND-2608). DIPC and IMDEA Nanociencia receive support from the “Severo Ochoa” Programme for Centres of Excellence in R&D (MINECO, Grants CEX2018-000867-S and CEX2020-001039-S, respectively). S.S. is grateful for financial support of the Calabria Region (Project POR Calabria, FSE/FESR 2014–2020)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

1-Benzamido-1,4-dihydropyridine derivatives as anticancer agents: in vitro and in vivo assays

  • Ardevines, Sandra
  • Auria-Luna, Fernando
  • Romanos, Eduardo
  • Fernández-Moreira, Vanesa
  • Benedi, Andrea
  • Gimeno, M. Concepción
  • Marzo, Isabel
  • Marqués-López, Eugenia
  • Herrera, Raquel P.
1,4-Dihydropyridine is a privileged scaffold present in many bioactive molecules, from coenzymes to commercially available drugs. Among other interesting properties, it has been found good anticancer activity in some of these 1,4-DHPs, therefore many research groups are trying to develop new compounds based on this structural core. For this purpose, in this work, a family of 23 new 1,4-dihydropyridines has been synthesized using hydrazide and malononitrile derivatives as precursors. This straightforward catalytic process has given rise to the desired products with moderate to excellent yields. All the compounds have been tested against four different cancer cell lines [HeLa (human cervical carcinoma), Jurkat (leukemia), A549 (human lung cancer) and MIA PaCa-2 (pancreatic cancer)] to establish a preliminary structure–activity relationship. From this study, and among the best candidates, we chose 4-chlorophenyl and 4-(trifluoromethyl)phenyl derivatives in the malononitrile ring to synthesize a second generation of molecules with enhanced cytotoxicity, modifying the substituent in the N-heterocyclic position (acylhydrazine moieties). With this second generation of compounds, we successfully decreased the IC50 until 7 µM. An in-depth analysis of their biological properties suggests that these promising compounds trigger a non-conventional cell death mechanism known as paraptosis. Moreover, the tested photophysical properties of these products show in some cases an interesting long wavelength emission and excitation, potentially leading to new biosensors or theragnostic agents. Finally, in vivo assays concerning the acute toxicity in mice of two of the most active compounds (with an alkyl chain of seven carbon atoms in the acylhydrazine moiety) demonstrated that even dosed at thousands fold the corresponding IC50 values (2500 and 3300 times more concentrated than the IC50 values for the two compounds studied), there was no sign of harmful effects on the tested subjects, results that support their use in further studies to discover new anticancer drugs., The authors thank Agencia Estatal de Investigación (AEI), project PID2019-104379RB-C21 and PID2020-117455GB-I00/AEI/10.13039/501100011033; RED2018-102471-T (MCIN/AEI/10.13039/501100011033), RTI2018-097836-J-I00 (MCIN/AEI/10.13039/501100011033/FEDER), RYC2018-025872-I (MCIN/AEI/10.13039/501100011033), by “ESF Investing in your future” and Gobierno de Aragón-Fondo Social Europeo (Research Groups E07_20R and B31_20R) for financial support of this research. S. A. thanks the DGA (Aragon Government) for a predoctoral fellowship., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Heterocycles in breast cancer treatment: The use of pyrazole derivatives

  • Ardevines, Sandra
  • Marqués-López, Eugenia
  • Herrera, Raquel P.
Among the aromatic heterocycle rings, pyrazole -a five-membered ring with two adjacent nitrogen atoms in its structure has been postulated as a potent candidate in the pharmacological context. This moiety is an interesting therapeutic target covering a broad spectrum of biological activities due to its presence in many natural substances. Hence, the potential of the pyrazole derivatives as antitumor agents has been explored in many investigations, showing promising results in some cases. In this sense, breast cancer, which is already the leading cause of cancer mortality in women in some countries, has been the topic selected for this review, which covers a range of different research from the earliest studies published in 2003 to the most recent ones in 2021., This research was funded by Agencia Estatal de Investigación (AEI), project PID2020-117455GB-I00/AEI/10.13039/501100011033; RED2018-102471-T/ AEI/10.13039/501100011033 and Gobierno de Aragón-Fondo Social Europeo (Research Group E07_20R)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The role of metallodrugs in cellular senescence

  • Redrado, Marta
  • Fernández-Moreira, Vanesa
Delivering alternative strategies to deal with cancer is a huge milestone in research. Cancer cells can give a senescence response as consequence of cellular stress or external stimuli such as the use of chemotherapies, which could end up eventually in cancer relapse. Controlling cellular senescence will surely open new cancer treatment approaches. Cancer senescence induction can be used as an added timeframe to look for alternative treatments and senolytic drugs to avoid cancer relapse destroying the senescent cells (SnCs). Within cancer senescence research, metal complexes are underdeveloped in comparison with that of organic molecules or nanoparticles. Herein, we highlight the scarce investigation performed with metal complexes in the field of senescence and how a great input on them could be a huge step towards the search of alternative cancer treatments., Authors thank the Agencia Estatal de Investigación, RTI2018-097836-J−I00 / MCIN / AEI /10.13039/501100011033/ FEDER, RYC2018-025872-I (funded by MCIN/AEI/ 10.13039/501100011033 and by “ESF Investing in your future”), RED2018-102471-T / MCIN/AEI /10.13039/501100011033, and Gobierno de Aragón-Fondo Social Europeo (E07_20R) for financial support. M.R. thanks the Gobierno de Aragón for a predoctoral fellowship. M.R. thanks Dr. D. Muñoz-Espín for the training and transfer of knowledge in cancer SnCs., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Antibacterial properties of phosphine gold(i) complexes with 5-fluorouracil

  • Ferrando, Ricardo
  • Mitchell, Scott G.
  • Atrián-Blasco, Elena
  • Cerrada, Elena
New gold(I) complexes with coordination to 5-fluorouracil (5-FU), an anticancer drug with antibacterial properties, have been synthesised and characterised, and are the first reported examples of 5-FU–Au compounds. These new complexes show high solution stability, even in the presence of a cysteine derivative, and so were evaluated as antibacterial compounds against model Gram-positive and Gram-negative bacteria. All the complexes show excellent antibacterial activity against Gram-positive B. subtilis, most of them improving the activity of 5-FU alone. Furthermore, these new complexes are also active against Gram-negative E. coli, where [Au(5-FU)(PTA)], the complex with the smallest phosphane, is the most bactericidal, 32 times more active than 5-FU on its own., This work was financially supported by MCIN-Agencia Estatal de Investigación Grants PID2019-104379RB-C21/AEI/10.13039/501100011033, and Red Multimetdrugs (RED2018-102471-T/MCIN/AEI/10.13039/501100011033) and Gobierno de Aragón (E07_20R, Fondos FEDER “otra manera de hacer Europa”). E. A. B. and S. G. M. acknowledge the funding from the European Union's Horizon 2020 research and innovation program (Marie Skłodowska-Curie grant agreement no. 845427) and from the internationalization program “MSCA-IF_ERC” of CSIC., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Silver-based terpyridine complexes as antitumor agents

  • Gil-Moles, María
  • Olmos, M. Elena
  • Monge, Miguel
  • Beltrán-Visiedo, Manuel
  • Marzo, Isabel
  • López-de-Luzuriaga, José M.
  • Gimeno, M. Concepción
Silver complexes bearing substituted terpyridine or tetra-2-pyridinylpyrazine ligands have been prepared and structurally characterised. The study of the anticancer properties of silver complexes with this type of ligands is scarce, despite the possibilities of combining the properties of the metal and the ability of the ligands for DNA binding. Here, the antiproliferative activity, stability, CT-DNA binding, and mechanism of cell death of these types of derivatives are studied. High cytotoxicity against different tumour cells was observed, and, more important, a great selectivity index has been detected between tumour cells and healthy lymphocytes T for some of these compounds. The CT-DNA interaction study has shown that these derivatives are able to interact with CT-DNA by moderate intercalation. Furthermore, cell death studies indicate that these derivatives promote the apoptosis by a mitochondrial pathway., Authors thank the Ministerio de Economía y Competitividad (MINECO-FEDER PID2019-104379RB-C21, PID2019-104379RB-C22/AEI/10.13039/501100011033, RED2018-102471-T (MCIN/AEI/10.13039/501100011033)) and Gobierno de Aragón-Fondo Social Europeo (E07_23R) for financial support. M. Gil-Moles acknowledges support by an FPI-MINECO Fellowship (BES-2014-070407)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Dithiobiureas Palladium(II) complexes' studies: From their synthesis to their biological action

  • Herrero, Jorge M.
  • Fabra, David
  • Matesanz, Ana I.
  • Hernández, Carolina
  • Sánchez-Pérez, Isabel
  • Quiroga, Adoración G.
Dithiobiureas coordination chemistry towards palladium (II) ions and their possible application is presented and discussed. 1,6-(4-Methoxyphenyl)-2,5-dithiobiurea and 1,6-(4-chlorophenyl)-2,5-dithiobiurea afford two Pd(II) complexes with the general formula [Pd2(H2L)Cl2(PPh3)2]. The metal ion forms one chelate ring with the dithiobiurea, and binds to a triphenylphosphine and an additional leaving group cisplatin like. One of the complexes (1) is endowed not only with stability in DMSO and aqua solutions containing a biological buffer but also with cytotoxicity versus gastric cancer cell lines. Complex 1 does not interact covalently to DNA models, neither activates p53 or Checkpoint Kinase 1 key proteins for DNA damage response. Thus, we propose that complex 1 exerts its action by activating Mitogen-Activated Protein Kinases [p38, Extracellular signal-regulated kinases (ERKs), c-Jun N-terminal kinases (JNKs)] as cell death inductors., We acknowledge to Spanish MICINNgrant PID2019-106220RB100 and MetDrugs Network RED2018-102471T and COST Action CA18202 for research discussion. JMH was supported by a grant FPI-UAM 2021 from Universidad Autónoma de Madrid (Molecular BioSciences PhD programme)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Synthesis and antiproliferative study of phosphorescent multimetallic Re(I)/Au(I) complexes containing fused imidazo[4,5-f]-1,10-phenanthroline core

  • Luengo, Andrés
  • Marzo, Isabel
  • Fernández-Moreira, Vanesa
  • Gimeno, M. Concepción
Five heterobimetallic ReI/AuI and a tri-metallic ReI/AuI/ReI species following the formulas fac-[ReCl (CO)3(N^N^CAuR)]0/+ and [(fac-[ReCl (CO)3(N^N^C)])2Au]+, where R is an iodide (1), phenylacetylene (2), dodecanethiol (3), 2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranose (4) and JohnPhos (5) and N^N^C is the fused imidazo[4,5-f]-1,10-phenanthroline heterotopic ligand, were synthesised and fully characterised by a variety of spectroscopic and analytical techniques. The resultant complexes are luminescent in the orange region, revealing classical metal-to-ligand charge transfer (3MLCT) ((Re (dπ) → (N^N^C)(π*)) emission in aerated DMSO solution. The red shifted emission observed on going from 3 to 4 suggests that the electronic properties of the gold ancillary ligand are implicated in the emissive properties. Antiproliferative activity in tumour cell lines, lung (A549) and cervix (HeLa) cells revealed that only complex 4 containing a 2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranose as gold ancillary ligand possesses certain cytotoxicity in both cell lines., Authors thank the Agencia Estatal de Investigación, projects PID2019-104379RB-C21/AEI /10.13039/501100011033, RTI2018-097836-J-I00/MCIN/AEI/10.13039/501100011033/FEDER, RYC2018-025872-I (funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”), RED2018-102471-T/MCIN/AEI/10.13039/501100011033, and Gobierno de Aragón-Fondo Social Europeo (E07_20R) for financial support. A.L. thanks the Gobierno de Aragón for a predoctoral fellowship., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Tesis doctoral (DoctoralThesis)

Evaluación del efecto antitumoral de nuevos complejos de oro(i) como potenciales agentes frente al cáncer colorrectal

  • Mármol, Inés
Programa de Doctorado en Ciencias Biomédicas y Biotecnológicas., [ES] Dada la creciente incidencia y la alta tasa de mortalidad del cáncer colorrectal en el mundo, es necesario desarrollar nuevos agentes quimioterapéuticos que sean a un tiempo eficaces y seguros. Para ello, debe optarse por compuestos capaces de actuar frente a dianas selectivas, como por ejemplo proteínas sobreexpresadas por la célula tumoral y que resulten clave para su correcto funcionamiento. En este sentido, destacan los complejos de oro(I) por su capacidad de inhibir a la enzima redox tiorredoxina reductasa, necesaria para mantener la homeostasis redox de la célula cancerígena. Sin embargo, el potencial antitumoral de los complejos de oro(I) va más allá de esta acción biológica. En la presente tesis doctoral se ha evaluado el efecto de una serie de derivados de oro(I) de nueva síntesis sobre la línea celular Caco-2 como un modelo de carcinoma de colon humano. Tras escoger a los más prometedores atendiendo a su IC50 e Índice de selectividad, se realizó un estudio en profundidad de su mecanismo de acción y el tipo de muerte celular inducida por cada uno de ellos. Se observaron algunos comportamientos no notificados hasta el momento, como la capacidad de uno de ellos de inducir formas de muerte celular alternativas a la apoptosis intrínseca o la afinidad hacia dianas no canónicas de otros de ellos. Los resultados obtenidos muestran el potencial de los complejos de oro(I) para el tratamiento del cáncer colorrectal y los posicionan como una interesante alternativa a la terapia basada en platino que se lleva a cabo en la actualidad., [EN] Given the incessant growth in colorectal cancer cases worldwide, the development of novel, safer and more effective therapeutic strategies is needed to improve both quality-of-life and life expectancy of patients. Gold(I) derivatives have arisen as a promising alternative to current platinum-containing drugs due to their affinity for proteins that are overexpressed on tumor cells. Therefore, this kind of drugs are supposed to be safer but to maintain the therapeutic efficacy of platinum-based metallodrugs. This Thesis has been focused on the evaluation of novel gold(I) complexes towards a model of colorectal cancer, Caco-2 cell line. The influence of coordination ligands on the biological effect of the resultant molecule has been in depth studied with a variety of assays that includes analysis of apoptotic populations, measurement of reactive oxygen species levels and analysis of certain enzymatic and proteic activities among others. Moreover, a novel drug combination containing an alkynyl gold(I) derivative and plant extracts has been developed, the antibacterial activity of a series of gold(I) derivatives has been evaluated according to drug repurposing philosofy and the replacement of gold(I) by silver(I) in regards to anti-colorectal cancer activity has been studied. Text has been structured on four chapters detailed below., Este trabajo ha sido financiado a través de los siguientes organismos y proyectos: - “REDVALUE: Alianza tecnológica para completar el ciclo agroindustrial y forestal”. Financiado con fondos FEDER. Año 2016. SOE1/P1/E0123 (convocatoria SUDOE INTERREG IVB de 2015). - “APLICACIONES DE COMPUESTOS DE ORO EN FOTOFÍSICA, MEDICINA Y CATÁLISIS”. Financiado por el Ministerio de Economía y Competitividad. Año 2016. CTQ2016-75816-C2-1-P - “BÚSQUEDA DE LOS MECANISMOS MOLECULARES DE LA ACCIÓN DEL ESCUALENO IN VITRO E IN VIVO”. Financiado por el Ministerio de Economía y Competitividad. Año 2016. SAF2016-75441-R - “METALOFÁRMACOS MULTIFUNCIONALES PARA DIAGNOSIS Y TERAPIA”. Financiado por Red Multimetdrugs. Año 2018. RED2018-102471-T. - “Dieta mediterránea y su potencial nutracéutico”. Financiado por Gobierno de Aragón. Año 2017. B16_R17. - “Química de oro y plata”. Financiado por Gobierno de Aragón. Año 2017. E07_17R, Peer reviewed
Repositorio Institucional de la Universidad de Burgos (RIUBU)
Publication Artículo científico (JournalArticle)

Conversion of a double-tetranuclear cluster silver helicate into a dihelicate via a rare desulfurization process

  • Fernández-Fariña, Sandra
  • González-Barcia, Luis M.
  • Romero, María J.
  • García Tojal, Javier
  • Maneiro, Marcelino
  • Seco, José M.
  • Zaragoza, Guillermo
  • Martínez-Calvo, Miguel
  • González-Noya, Ana M.
  • Pedrido Castiñeiras, Rosa
We present the first example of a silver double-tetranuclear cluster helicate [Ag4L2]2 obtained from a bisthiosemicarbazone ligand using electrochemical synthesis. This cluster helicate undergoes a rare desulfurization process in chloroform giving rise to a cationic silver dihelicate [Ag2(H2L)2]SO4. This is the first silver mediated desulfurization reaction., FEDER cofunded-grants: from Consellería de Cultura, Educación e Ordenación Universitaria, Xunta de Galicia, 2017 GRC GI-1682 (ED431C 2017/01), 2018 GRC GI-1584 (ED431C 2018/13), MetalBIO Network (ED431D 2017/01), Ministerio de Ciencia, Innovación y Universidades, METALBIO (CTQ2017-90802-REDT) and MultiMetDrugs (RED2018-102471-T).
Repositorio Institucional de la Universidad de Burgos (RIUBU)
Publication Artículo científico (JournalArticle)

Photocatalytic Aerobic Dehydrogenation of N-Heterocycles with Ir(III) Photosensitizers Bearing the 2(2′-Pyridyl)benzimidazole Scaffold

  • Echevarría Poza, Igor
  • Vaquero Gutiérrez, Mónica
  • Manzano, Blanca R.
  • Jalón Sotés, Félix Ángel
  • Quesada Pato, Roberto
  • Espino Ordóñez, Gustavo
Photoredox catalysis constitutes a very powerful tool in organic synthesis, due to its versatility, efficiency, and the mild conditions required by photoinduced transformations. In this paper, we present an efficient and selective photocatalytic procedure for the aerobic oxidative dehydrogenation of partially saturated N-heterocycles to afford the respective N-heteroarenes (indoles, quinolines, acridines, and quinoxalines). The protocol involves the use of new Ir(III) biscyclometalated photocatalysts of the general formula [Ir(C^N)2(N^N′)]Cl, where the C^N ligand is 2- (2,4-difluorophenyl)pyridinate, and N^N′ are different ligands based on the 2-(2′-pyridyl)benzimidazole scaffold. In-depth electrochemical and photophysical studies as well as DFT calculations have allowed us to establish structure−activity relationships, which provide insights for the rational design of efficient metal-based dyes in photocatalytic oxidation reactions. In addition, we have formulated a dual mechanism, mediated by the radical anion superoxide, for the above-mentioned transformations., We acknowledge the financial support provided by the Spanish Ministerio de Ciencia, Innovación y Universidades (RTI2018- 100709-B-C21 and CTQ (QMC)-RED2018-102471-T), Consejería de Educación de la Junta de Castilla y León and FEDER (BU087G19 and BU067P20), and Junta de Comunidades de Castilla-La Mancha-FEDER (JCCM) (grant SBPLY/19/ 180501/000260). I.E. acknowledges his fellowship to both the European Social Fund and Consejería de Educación de la Junta de Castilla y León (EDU/1100/2017). We are also indebted to J. Delgado, P. Castroviejo, and M. Mansilla (PCT of the Universidad de Burgos) for technical support, G. GarcíaHerbosa for providing us access to CV equipment, and J. V. Cuevas-Vicario for support with Gaussian.
Repositorio Institucional de la Universidad de Burgos (RIUBU)
Publication Artículo científico (JournalArticle)

Rational design of mitochondria targeted thiabendazole-based Ir(III) biscyclometalated complexes for a multimodal photodynamic therapy of cancer

  • Echevarría Poza, Igor
  • Zafon, Elisenda
  • Barrabés, Sílvia
  • Martínez, María Ángeles
  • Ramos Gómez, Sonia
  • Ortega Santamaría, Natividad
  • Manzano, Blanca R.
  • Jalón Sotés, Félix Ángel
  • Quesada Pato, Roberto
  • Espino Ordóñez, Gustavo
  • Massaguer Vall-Llovera, Anna
Despite their outstanding properties as potential photosensitizers for photodynamic therapy (PDT), Ir(III) biscyclometalated complexes need both further developments to overcome remaining limitations and in-depth investigations into their mechanisms of action to reach clinic application in the treatment of cancer. This work describes the synthesis of a family of Ir(III) complexes of general formula [Ir(C^N)2(N^N′ )]Cl (N^N′ = thiabendazole-based ligands; C^N = ppy (2-phenylpyridinate) (Series A), or dfppy (2-(2,4-difluorophenyl)pyridinate) (Series B)) and their evaluation as potential PDT agents. These complexes are partially soluble in water and exhibit cytotoxic activity in the absence of light irradiation versus several cancer cell lines. Furthermore, the cytotoxic activity of derivatives of Series A is enhanced upon irradiation, particularly for complexes [1a]Cl and [3a]Cl, which show phototoxicity indexes (PI) above 20. Endocytosis was established as the uptake mechanism for [1a]Cl and [3a]Cl in prostate cancer cells by flow cytometry. These derivatives mainly accumulate in the mitochondria as shown by colocalization confocal microscopy experiments. Presumably, [1a]Cl and [3a]Cl induce death on cancer cells under irradiation through apoptosis triggered by a multimodal mechanism of action, which likely involves damage over mitochondrial DNA and mitochondrial membrane depolarization. Both processes seem to be the result of photocatalytic oxidation processes., We acknowledge the financial support provided by the Spanish Ministerio de Ciencia, Innovacion ´ y Universidades (RTI2018-100709-BC21, RTI2018-100709-B-C22) and CTQ (QMC)-RED2018-102471-T), Junta de Castilla y Leon ´ (BU087G19), Junta de Comunidades de CastillaLa Mancha-FEDER (JCCM) (grant SBPLY/19/180501/000260) and UCLM-FEDER (grants 2019-GRIN-27183 and 2019-GRIN-27209). I. Echevarría wants to acknowledge his fellowship to both the European Social Fund and Consejería de Educacion ´ de la Junta de Castilla y Leon ´ (EDU/1100/2017). E. Zafon wants to acknowledge her predoctoral fellowship to the Generalitat de Catalunya (AGAUR; 2021 FI_B 01036). We are also indebted to Jacinto Delgado, Pilar Castroviejo and Marta Mansilla (PCT of the Universidad de Burgos) for technical support and Jos´e Vicente Cuevas Vicario for advice and support with theoretical calculations and Gabriel García-Herbosa for providing us access to CV equipment.
Repositorio Institucional de la Universidad de Burgos (RIUBU)
Publication Artículo científico (JournalArticle)

Thiosemicarbazonecopper/Halido Systems: Structure and DFT Analysis of the Magnetic Coupling

  • Jiménez Pérez, Alondra
  • Marcos-Gómez, Sara
  • Madariaga, Gotzon
  • Zapico, Manuel
  • Vitoria, Pablo
  • Tercero, Javier
  • Torres, M. Begoña
  • Lezama, Luis
  • Cuevas Vicario, José Vicente
  • Etxebarria, Íñigo
  • García Tojal, Javier
Experimental magnetic studies performed on the [{CuLX}2 ] system (HL = pyridine-2- carbaldehyde thiosemicarbazone, X = Cl−, Br−, I−) point to the larger electronegativity in X, the lower magnitude of the antiferromagnetic interactions. In order to confirm this and other trends observed and to dip into them, computational studies on the [{CuLX}2 ] (X = Cl− (1), I− (2)) compounds are here reported. The chemical and structural comparisons have been extended to the compounds obtained in acid medium. In this regard, chlorido ligands yield the [Cu(HL)Cl2 ]·H2O (3) complex, whose crystal structure shows that thiosemicarbazone links as a tridentate chelate ligand to square pyramidal Cu(II) ions. On the other hand, iodido ligands provoke the formation of the [{Cu(H2L)I2 }2 ] (4) derivative, which contains pyridine-protonated cationic H2L + as a S-donor monodentate ligand bonded to Cu(I) ions. Crystallographic, infrared and electron paramagnetic resonance spectroscopic results are discussed. Computational calculations predict a greater stability for the chlorido species, containing both the neutral (HL) and anionic (L−) ligand. The theoretical magnetic studies considering isolated dimeric entities reproduce the sign and magnitude of the antiferromagnetism in 1, but no good agreement is found for compound 2. The sensitivity to the basis set and the presence of interdimer magnetic interactions are debated., This research was funded by the European Union H2020-LC-SC3-2020-NZE-RES-CC, NMBP-16-2020-GA 953152 and DT-NMBP-04-2020 Projects, together with the Ministerio de Ciencia, Innovación y Universidades CTQ(QMC) RED2018-102471-T MultiMetDrugs Network (Spain), PGC2018-093745-B-I00 and PID2019-111215RB-100, Consejería de Educación of Junta de Castilla y León and FEDER BU049P20 and FUNDACION BANCARIA CAIXA D. ESTALVIS I PENSIONS DE BARCELONA 001. Ministerio de Ciencia e Innovación PID2019-106644GB-I00 and Gobierno Vasco IT1458-22.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Ultrasound-assisted multicomponent synthesis of 4H-pyrans in water and DNA binding studies

  • Auria-Luna, Fernando
  • Fernández-Moreira, Vanesa
  • Marqués-López, Eugenia
  • Gimeno, M. Concepción
  • Pérez Herrera, Raquel
A simple approach to synthesize new highly substituted 4H-pyran derivatives is described. Efficient Et3N acts as a readily accessible catalyst of this process performed in pure water and with only a 20 mol% of catalyst loading. The extremely simple operational methodology, short reaction times, clean procedure and excellent product yields render this new approach extremely appealing for the synthesis of 4H-pyrans, as potentially biological scaffolds. Additionally, DNA interaction analysis reveals that 4H-pyran derivatives behave preferably as minor groove binders over major groove or intercalators. Therefore, this is one of the scarce examples where pyrans have resulted to be interesting DNA binders with high binding constants (Kb ranges from 1.53 × 104 M-1 to 2.05 × 106 M-1).
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Heterobimetallic propargyl gold complexes with p-bound copper or silver with enhanced anticancer activity

  • Johnson, Alice
  • Marzo, Isabel
  • Gimeno, M. Concepción
Several propargyl functionalised substrates with different heteroatoms (N, O or S) have been used for the preparation of propargyl gold(i) phosphine complexes. The complexes were prepared in high yields either by reaction of the substrate with [Au(acac)PPh3] or by reaction of [AuCl(PPh3)] with potassium hydroxide and the substrate in methanol. Several of the complexes have been characterised by X-ray diffraction showing the presence of secondary bonds such as p-stacking and aurophilic interactions. The reaction of the propargyl gold(i) phosphine complexes with [Cu(NO3)(PPh3)2] or [Ag(OTf)(PPh3)2] afforded heterobimetallic complexes with p-coordination of {Cu(PPh3)2} or {Ag(PPh3)2} to the alkyne bond. When the substituent of the propargyl unit contained more strongly coordinating pyridine moieties, [(PyCH2)2NCH2CCAuPPh3], coordination of the heterometal to the pyridine units occurred, displacing the phosphine groups and giving rise to a dimeric structure. The antiproliferative activity of the complexes against cisplatin resistant lung cancer cell line A549 was determined by MTT assay. The mononuclear gold complexes showed excellent activities with IC50 values < 14 µM. Coordination of copper of silver to the alkynyl fragment resulted in a significant increase in activity suggesting a synergistic effect between the two metal centres.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Self-Assembly of Hollow Organic Nanotubes Driven by Arene Regioisomerism

  • Alegre-Requena, J.V.
  • Pérez Herrera, Raquel
  • Díaz Díaz, D.
Arene regioisomerism in low-molecular-weight gelators can be exploited as a tool to modulate the micro-structures of the corresponding xerogel networks by using the three different possible substitution patterns ortho, meta and para. This aromatic regioisomer-driven strategy has been used with a cholesterol-based gelator to prepare hollow self-assembled organic nanotubes (S-ONTs) with inside and outside diameters of ca. 35 and 140 nm, respectively. Electron microscopy imaging and theoretical calculations were employed to rationalize the formation mechanism of these S-ONTs. From the three possible regioisomers, only the ortho-disubstituted cholesteryl-based gelator showed the optimal angle and distance between substituents to afford the formation of the cyclic assemblies required for nanotube growth by assembling 30–40 units of the gelator. This study opens fascinating opportunities to expand the synthesis of controllable and unique microstructures by modulating geometrical parameters through aromatic regioisomers.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Luminescent Bimetallic IrIII /AuI Peptide Bioconjugates as Potential Theranostic Agents

  • Luengo, A.
  • Marzo, I.
  • Reback, M.
  • Daubit, I.M.
  • Fernández-Moreira, V.
  • Metzler-Nolte, N.
  • Gimeno, M.C.
Diverse iridium peptide bioconjugates and the corresponding iridium/gold bimetallic complexes have been synthesized starting from a cyclometallated carboxylic acid substituted IrIII complex [Ir(ppy)2 (Phen-5-COO)] by solid phase peptide synthesis (SPPS). The selected peptide sequences were an enkephalin derivative Tyr-Gly-Gly-Phe-Leu together with the propargyl-substituted species Tyr-Gly-Pgl-Phe-Leu to allow gold coordination (Pgl: propyrgyl-glycine, HC=C-Gly), and a specific short peptide, Ala-Cys-Ala-Phen, containing a cysteine residue. Introduction of the gold center has been achieved via a click reaction with the alkynyl group leading to an organometallic Au-C(triazole) species, or by direct coordination to the sulfur atom of the cysteine. The photophysical properties of these species revealed predominantly an emission originating from the Ir complex, using mixed metal-to-ligand and ligand-to-ligand charge transfer excited states of triplet multiplicity. The formation of the peptide bioconjugates caused a systematic redshift of the emission profiles. Lysosomal accumulation was observed for all the complexes, in contrast to the expected mitochondrial accumulation triggered by the gold complexes. Only the cysteine-containing Ir/Au bioconjugate displayed cytotoxic activity. The absence of activity may be related to the lack of endosomal/lysosomal escape for the cationic peptide conjugates. Interestingly, the different coordination sphere of the gold atom may play a crucial role, as the Au-S(cysteine) bond may be more readily cleaved in a biological environment than the Au-C(triazole) bond, and thus the Au fragment could be released from or trapped in the lysosomes, respectively. This work represents a starting point in the development of bimetallic peptide bioconjugates as theranostics and in the knowledge of factors that contribute to anti-proliferative activity.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Time-Dependent Cytotoxic Properties of Terpyridine-Based Copper Complexes

  • Grau, J.
  • Caubet, A.
  • Roubeau, O.
  • Montpeyó, D.
  • Lorenzo, J.
  • Gamez, P.
Five copper complexes supported by terpyridine ligands were prepared and characterized, viz. [Cu3Cl4(naphtpy)2][CuCl2] (1), [Cu2Cl2(naphtpy)2](ClO4)2 (2), [CuCl2(naphtpy)]2(MeOH)3(H2O) (3), [CuCl2(Cltpy)] (4) and [Cu(Cltpy)2](ClO4)2 (5); (where naphtpy stands for 4’-((naphthalen-2-yl)methoxy)-2, 2':6', 2''-terpyridine and Cltpy for 4'-chloro-2, 2':6', 2''-terpyridine). Their ability to interact with DNA was investigated, and their cytotoxic behaviour was examined with three cells lines, namely human ovarian carcinoma cells (A2780), their derived cisplatin-resistant line (A2780cis), and human cervix adenocarcinoma cells (HeLa). All compounds show good cytotoxic properties (especially after 72 h of incubation). Remarkably, two compounds, 4 and 5, are still almost inactive after 24 h (particularly 4), but are highly active after 72 h, with IC50 values in the low-micromolar to sub-micromolar range. Compounds 1 and 2 induce necrosis, whereas late apoptosis is observed with 3–5, 4 exhibiting a behaviour close to that of cisplatin.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Luminescent Re(I)/Au(I) Species As Selective Anticancer Agents for HeLa Cells

  • Luengo, Andrés
  • Redrado, Marta
  • Marzo, Isabel
  • Fernández-Moreira, Vanesa
  • Gimeno, M.Concepción
A series of neutral and cationic heterotrimetallic complexes of the type fac-[Re(CO)3(bipy(CC)2-(AuL)2)X]n, where bipy(CC)2 is 4, 4'-alkynyl-2, 2'-bipyridine; L is either triphenylphosphine (PPh3), [1, 3-bis(2, 6-diisopropylphenyl)-imidazol-2-ylidene] (IPr), or tert-butyl isocyanide (CNtBu); and X is a chloride (n = 0) or acetonitrile (n = 1), were synthesized and characterized together with their Re(I) precursors, i.e., fac-[Re(CO)3(bipy(CC)2)X]n. X-ray diffraction of complexes 1, 3, and 6 corroborated the expected octahedral and linear distribution of the ligands along the Re(I) and Au(I) centers, respectively. Luminescent studies showed that all the complexes displayed a broad emission band centered between 565 and 680 nm, corresponding to a 3MLCT from the Re(I) to the diimine derivative. The presence of the gold fragment coordinated to the diimine ligand shifted in all cases the emission maxima toward higher energies. Such an emission difference could be potentially used for assessing the precise moment of interaction of the probe with the biological target if the gold fragment is implicated. Antiproliferative studies in cancer cells, A549 (lung cancer) and HeLa (cervix cancer), showed a generalized selectivity toward HeLa cells for those heterotrimetallic species incubated at longer times (72 vs 24 h). ICP-MS spectrometry revealed the greater cell internalization of cationic vs neutral species. Preliminary fluorescence microscopy experiments showed a different behavior of the complexes in HeLa and A549 cell lines. Whereas the complexes in A549 were randomly distributed in the outside of the cell, those incubated with HeLa cells were located close to the cellular membrane, suggesting some type of interaction, and possibly explaining their cellular selectivity when it comes to the antiproliferative activity displayed in the different cell lines.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Gold(I) and Silver(I) Complexes with 2-Anilinopyridine-Based Heterocycles as Multitarget Drugs against Colon Cancer

  • Mármol, I.
  • Montanel-Perez, S.
  • Royo, J.C.
  • Gimeno, M.C.
  • Villacampa, M.D.
  • Rodríguez-Yoldi, M.J.
  • Cerrada, E.
A series of gold(I) and silver(I) derivatives with N- or S-donor ligands derived from 2-anilinopyridine has been synthesized and characterized. The mononuclear structure of [Au(L1)(PPh3)](TfO) (1a) and [Au(L2)(PPh3)](TfO) (1b) was confirmed by X-ray diffraction studies, as well as the dinuclear structure in the case of [Ag(TfO)(L1)]2 (4a). Most of the complexes are cytotoxic against a model of colorectal adenocarcinoma (Caco-2 cell line) and breast adenocarcinoma cancer cell lines (MCF-7). [Au(L1)(PPh3)](TfO) (1a) was able to induce caspases 8 and 3 activation, loss of mitochondrial membrane potential, and reactive oxygen species (ROS)-dependent cell death on Caco-2 cells upon 24 h incubation. In addition, the gold complex 1a produced a significant inhibition of the redox enzyme thioredoxin reductase as well as 20S proteasome. However, the silver(I) analogue, [Ag(TfO)(L1)(PPh3)] (2a), induced cell death independent of inhibition of thioredoxin reductase and 20S proteasome, triggered ROS-independent apoptosis mediated by caspase 8 and 3 activation, and loss of mitochondrial membrane potential, which points to a different mechanism of action for both derivatives, dependent on the metal center.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Theranostics Through the Synergistic Cooperation of Heterometallic Complexes

  • Redrado, M.
  • Fernández-Moreira, V.
  • Gimeno, M.C.
Heterometallic drugs are emerging as a great alternative to conventional metallodrugs. Careful selection of different metallic fragments makes possible to enhance not only the therapeutic potential by a synergistic effect, but also to incorpore key features like traceability. Drugs that integrate traceability and therapy in one system are known as theranostic agents. In cancer research, theranostic agents are becoming increasingly important. They deliver crucial information regarding their biological interplay that can ultimately be used for optimization. The well-established therapeutic potential of PtII-, RuII- and AuI-based drugs combined with the outstanding optical properties of d6 transition metal complexes grant the delivery of traceable metallodrugs. These species can be easily fine-tuned through modification of their respective ligands to provide a new generation of drugs.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Unveiling the Antioxidant Therapeutic Functionality of Sustainable Olive Pomace Active Ingredients

  • Quero, J.
  • Ballesteros, L. F.
  • Ferreira-Santos, P.
  • Velderrain-Rodriguez, G.
  • Rocha, C. M. R.
  • Pereira, R. N.
  • Teixeira, J. A.
  • Martin-Belloso, O.
  • Osada, J.
  • Rodríguez-Yoldi, M. J.
Olive pomace (OP) is the main residue that results from olive oil production. OP is rich in bioactive compounds, including polyphenols, so its use in the treatments of diseases related to oxidative stress, such as cancer, could be considered. The present work aimed to study the biological properties of different OP extracts, obtained by ohmic heating-assisted extraction and conventional heating, using water and 50% ethanol, in the treatment and prevention of colorectal cancer through Caco-2 cell models. Additionally, an in-silico analysis was performed to identify the phenolic intestinal absorption and Caco-2 permeability. The extracts were chemically characterized, and it was found that the Ohmic-hydroethanolic (OH-EtOH) extract had the highest antiproliferative effect, probably due to its higher content of phenolic compounds. The OH-EtOH induced potential modifications in the mitochondrial membrane and led to apoptosis by cell cycle arrest in the G1/S phases with activation of p53 and caspase 3 proteins. In addition, this extract protected the intestine against oxidative stress (ROS) caused by H2 O2. Therefore, the bioactive compounds present in OP and recovered by applying a green technology such as ohmic-heating, show promising potential to be used in food, nutraceutical, and biomedical applications, reducing this waste and facilitating the circular economy. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Multifunctional heterometallic Iriii-Aui probes as promising anticancer and antiangiogenic agents

  • Redrado M.
  • Benedi A.
  • Marzo I.
  • García-Otín A.L.
  • Fernández-Moreira V.
  • Gimeno M. Concepción
A new class of emissive cyclometallated IrIII-AuI complexes with a bis(diphenylphosphino) methanide bridging ligand was successfully synthesised from the diphosphino complex [Ir(N^C)2(dppm)]+ (1). The different gold ancillary ligand, a triphenylphosphine (2), a chloride (3) or a thiocytosine (4) did not reveal any significant effect on the photophysical properties, which are mainly due to metal-to-ligand charge-transfer (3MLCT) transitions based on IrIII. However, the AuI fragment, along with the ancillary ligand, seemed crucial for the bioactivity in A549 lung carcinoma cells versus endothelial cells. Both cell types display variable sensitivities to the complexes (IC50=0.6–3.5 µM). The apoptotic pathway is activated in all cases, and paraptotic cell death seems to take place at initial stages in A549 cells. Species 2–4 showed at least dual lysosomal and mitochondrial biodistribution in A549 cells, with an initial lysosomal localisation and a possible trafficking process between both organelles with time. The bimetallic IrIII-AuI complexes disrupted the mitochondrial transmembrane potential in A549 cells and increased reactive oxygen species (ROS) generation and thioredoxin reductase (TrxR) inhibition in comparison with that displayed by the monometallic complex 1. Angiogenic activity assays performed in endothelial cells revealed the promising antimetastatic potential of 1, 2 and 4. © 2021 The Authors. Chemistry - A European Journal published by Wiley-VCH GmbH.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Synthesis and antiproliferative study of phosphorescent multimetallic Re(I)/Au(I) complexes containing fused imidazo[4, 5-f]-1, 10-phenanthroline core

  • Luengo, Andres
  • Marzo, Isabel
  • Fernandez-Moreira, Vanesa
  • Gimeno, M. Concepcion
Five heterobimetallic Re-I/Au-I and a tri-metallic Re-I/Au-I/Re-I species following the formulas fac-ReCl (CO)(3)(NNCAuR)](0/+) and (fac-ReCl (CO)(3)(NNC)])(2)Au](+), where R is an iodide (1), phenylacetylene (2), dodecanethiol (3), 2, 3, 4, 6-tetra-O-acetyl-1-thio-beta-D-glucopyranose (4) and JohnPhos (5) and NNC is the fused imidazo4, 5-f]-1, 10-phenanthroline heterotopic ligand, were synthesised and fully characterised by a variety of spectroscopic and analytical techniques. The resultant complexes are luminescent in the orange region, revealing classical metal-to-ligand charge transfer ((MLCT)-M-3) ((Re (d pi) -> (NNC)(pi*)) emission in aerated DMSO solution. The red shifted emission observed on going from 3 to 4 suggests that the electronic properties of the gold ancillary ligand are implicated in the emissive properties. Antiproliferative activity in tumour cell lines, lung (A549) and cervix (HeLa) cells revealed that only complex 4 containing a 2, 3, 4, 6-tetra-O-acetyl-1-thio-beta-D-glucopyranose as gold ancillary ligand possesses certain cytotoxicity in both cell lines.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Gold(I) complexes bearing alkylated 1, 3, 5-triaza-7-phosphaadamantane ligands as thermoresponsive anticancer agents in human colon cells

  • Quero J.
  • Ruighi F.
  • Osada J.
  • Gimeno M.C.
  • Cerrada E.
  • Rodriguez-Yoldi M.J.
Overheating can affect solubility or lipophilicity, among other properties, of some an-ticancer drugs. These temperature-dependent changes can improve efficiency and selectivity of the drugs, since they may affect their bioavailability, diffusion through cell membrane or activity. One recent approach to create thermosensitive molecules is the incorporation of fluorine atoms in the chemical structure, since fluor can tune some chemical properties such as binding affinity. Herein we report the anticancer effect of gold derivatives with phosphanes derived from 1, 3, 5-triaza-7-phosphaadamantane (PTA) with long hydrocarbon chains and the homologous fluorinated chains. Besides, we analysed the influence of temperature in the cytotoxic effect. The studied gold(I) complexes with phosphanes derived from PTA showed antiproliferative effect on human colon carcinoma cells (Caco-2/TC7 cell line), probably by inhibiting cellular TrxR causing a dysfunction in the intracellular redox state. In addition, the cell cycle was altered by the activation of p53, and the complexes produce apoptosis through mitochondrial depolarization and the consequent activation of caspase-3. Furthermore, the results suggest that this cytotoxic effect is enhanced by hyperthermia and the presence of polyfluorinated chains. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Sulfonamide-derived Dithiocarbamate Gold(i) complexes induce the apoptosis of colon cancer cells by the activation of Caspase 3 and redox imbalance

  • Quero, Javier
  • Royo, José Carlos
  • Fodor, Beatrice
  • Gimeno, María Concepción
  • Osada, Jesús
  • Rodríguez Yoldi, María Jesús
  • Cerrada, Elena
Two new families of dithiocarbamate gold(I) complexes derived from benzenesulfonamide with phosphine or carbene as ancillary ligands have been synthesized and characterized. In the screening of their in vitro activity on human colon carcinoma cells (Caco-2), we found that the more lipophilic complexes—those with the phosphine PPh3—exhibited the highest anticancer activity whilst also displaying significant cancer cell selectivity. Au(S2CNHSO2C6H5)(PPh3)] (1) and Au(S2CNHSO2-p-Me-C6H4)(IMePropargyl)] (8) produce cell death, probably by intrinsic apoptosis (mitochondrial membrane potential modification) and caspase 3 activation, causing cell cycle arrest in the G1 phase with p53 activation. Besides this, both complexes might act as multi-target anticancer drugs, as they inhibit the activity of the enzymes thioredoxin reductase (TrxR) and carbonic anhydrase (CA IX) with the alteration of the redox balance, and show a pro-oxidant effect.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Tunable Emissive Ir(III) Benzimidazole-quinoline Hybrids as Promising Theranostic Lead Compounds

  • Redrado, Marta
  • Miñana, Miriam
  • Coogan, Michael P.
  • Gimeno, M. Concepción
  • Fernández Moreira, Vanesa
Bioactive and luminescent cyclometallated Ir(III) complexes Ir(ppy)2L1]Cl (1) and Ir(ppy)2L2]Cl (2) containing a benzimidazole derivative (L1/L2) as auxiliary mimic of a nucleotide have been synthesised. The emissive properties of both complexes are conditioned by the nature of L1 and L2, rendering an orange and a green emitter respectively. Both are highly emissive with quantum yield increasing in absence of oxygen up to 0.26 (1) and 0.36 (2), suggesting their phosphorescent character. Antiproliferative activity against lung cancer A549 cells increased up to 15 times upon irradiation conditions, reaching IC50 values in the nanomolar range (0.3±0.09 µM (1) and 0.26±0.14 µM (2)) and pointing them as good PSs candidates for photodynamic therapy via 1O2 generation. Cellular biodistribution analysis by fluorescence microscopy suggest the lysosomes as the preferential accumulation organelle. Time-resolved studies showed a greatly increased cellular emission lifetime compared to the solution values, indicating binding to macromolecules or cellular structures and restriction of collision and vibrational quenching.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Biological Activity of NHC-Gold-Alkynyl Complexes Derived from 3-Hydroxyflavones

  • Mármol, Inés
  • Quero, Javier
  • Azcárate, Paula
  • Atrián-Blasco, Elena
  • Ramos, Carla
  • Santos, Joana
  • Gimeno, María Concepción
  • Rodríguez-Yoldi, María Jesús
  • Cerrada, Elena
In this paper we describe the synthesis of new N-heterocyclic carbene (NHC) gold(I) derivatives with flavone-derived ligands with a propargyl ether group. The compounds were screened for their antimicrobial and anticancer activities, showing greater activity against bacteria than against colon cancer cells (Caco-2). Complexes [Au(L2b)(IMe)] (1b) and [Au(L2b)(IPr)] (2b) were found to be active against both Gram-positive and Gram-negative strains. The mechanism of action of 1b was evaluated by measurement of thioredoxin reductase (TrxR) and dihydrofolate reductase (DHFR) activity, besides scanning electron microscopy (SEM). Inhibition of the enzyme thioredoxin reductase is not observed in either Escherichia Coli or Caco-2 cells; however, DHFR activity is compromised after incubation of E. coli cells with complex 1b. Moreover, loss of structural integrity and change in bacterial shape is observed in the images obtained from scanning electron microscopy (SEM) after treatment E. coli cells with complex 1b.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Synthesis of Dipyridylaminoperylenediimide–Metal Complexes and Their Cytotoxicity Studies

  • Garcés-Garcés, José
  • Redrado, Marta
  • Sastre-Santos, Ángela
  • Gimeno, María Concepción
  • Fernández-Lázaro, Fernando
A new family of perylenediimide (PDI) silver and copper complexes has been successfully synthesized by reacting ortho- and bay-substituted (dipyrid-2′,2″-ylamino)perylenediimide ligands with metal phosphine fragments. The coordination of the metal center did not reveal a significant effect on the photophysical properties, which are mainly due to the PDI ligands, and in some cases quenching of the luminescence was observed. The antiproliferative effect of the free perylenediimide ligands and the metalloPDI complexes against the cervix cancer cell line HeLa was determined by MTT assay. The free perylenediimide ligands exhibited a moderate cytotoxic activity, but the coordination of silver or copper to the dypyridylamino fragment greatly enhanced the activity, suggesting a synergistic effect between the two fragments. In attempts to elucidate the cellular biodistribution of the PDIs and the complexes, a colocalization experiment using specific dyes for the lysosomes or mitochondria as internal standards revealed a major internalization inside the cell for the metal complexes, as well as a partial mitochondrial localization.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

The role of metallodrugs in cellular senescence

  • Redrado, Marta
  • Fernández-Moreira, Vanesa
Delivering alternative strategies to deal with cancer is a huge milestone in research. Cancer cells can give a senescence response as consequence of cellular stress or external stimuli such as the use of chemotherapies, which could end up eventually in cancer relapse. Controlling cellular senescence will surely open new cancer treatment approaches. Cancer senescence induction can be used as an added timeframe to look for alternative treatments and senolytic drugs to avoid cancer relapse destroying the senescent cells (SnCs). Within cancer senescence research, metal complexes are underdeveloped in comparison with that of organic molecules or nanoparticles. Herein, we highlight the scarce investigation performed with metal complexes in the field of senescence and how a great input on them could be a huge step towards the search of alternative cancer treatments.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

1-Benzamido-1,4-dihydropyridine derivatives as anticancer agents: in vitro and in vivo assays

  • Ardevines, Sandra
  • Auria-Luna, Fernando
  • Romanos, Eduardo
  • Fernández-Moreira, Vanesa
  • Benedi, Andrea
  • Gimeno, M. Concepción
  • Marzo, Isabel
  • Marqués-López, Eugenia
  • Herrera, Raquel P.
1,4-Dihydropyridine is a privileged scaffold present in many bioactive molecules, from coenzymes to commercially available drugs. Among other interesting properties, it has been found good anticancer activity in some of these 1,4-DHPs, therefore many research groups are trying to develop new compounds based on this structural core. For this purpose, in this work, a family of 23 new 1,4-dihydropyridines has been synthesized using hydrazide and malononitrile derivatives as precursors. This straightforward catalytic process has given rise to the desired products with moderate to excellent yields. All the compounds have been tested against four different cancer cell lines [HeLa (human cervical carcinoma), Jurkat (leukemia), A549 (human lung cancer) and MIA PaCa-2 (pancreatic cancer)] to establish a preliminary structure–activity relationship. From this study, and among the best candidates, we chose 4-chlorophenyl and 4-(trifluoromethyl)phenyl derivatives in the malononitrile ring to synthesize a second generation of molecules with enhanced cytotoxicity, modifying the substituent in the N-heterocyclic position (acylhydrazine moieties). With this second generation of compounds, we successfully decreased the IC50 until 7 µM. An in-depth analysis of their biological properties suggests that these promising compounds trigger a non-conventional cell death mechanism known as paraptosis. Moreover, the tested photophysical properties of these products show in some cases an interesting long wavelength emission and excitation, potentially leading to new biosensors or theragnostic agents. Finally, in vivo assays concerning the acute toxicity in mice of two of the most active compounds (with an alkyl chain of seven carbon atoms in the acylhydrazine moiety) demonstrated that even dosed at thousands fold the corresponding IC50 values (2500 and 3300 times more concentrated than the IC50 values for the two compounds studied), there was no sign of harmful effects on the tested subjects, results that support their use in further studies to discover new anticancer drugs.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Catalysis-free synthesis of thiazolidine–thiourea ligands for metal coordination (Au and Ag) and preliminary cytotoxic studies

  • Salvador-Gil, Daniel
  • P. Herrera, Raquel
  • Gimeno, M. Concepción
The reaction of propargylamines with isothiocyanates results in the selective formation of iminothiazolidines, aminothiazolines or mixed thiazolidine–thiourea compounds under mild conditions. It has been observed that secondary propargylamines lead to the selective formation of cyclic 2-amino-2-thiazoline derivatives, while primary propargylamines form iminothiazoline species. In addition, these cyclic thiazoline derivatives can further react with an excess of isothiocyanate to give rise to thiazolidine–thiourea compounds. These species can also be achieved by reaction of propargylamines with isothiocynates in a molar ratio of 1 : 2. Coordination studies of these heterocyclic species towards silver and gold with different stoichiometries have been carried out and complexes of the type [ML(PPh3)]OTf, [ML2]OTf (M = Ag, Au) or [Au(C6F5)L] have been synthesised. Preliminary studies of the cytotoxic activity in lung cancer cells have also been performed in both ligands and complexes, showing that although the ligands do not exhibit anticancer activity, their coordination to metals, especially silver, greatly enhances the cytotoxic activity.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Silver-based terpyridine complexes as antitumor agents

  • Gil-Moles, María
  • Olmos, M. Elena
  • Monge, Miguel
  • Beltrán-Visiedo, Manuel
  • Marzo, Isabel
  • López-de-Luzuriaga, José M.
  • Gimeno, M. Concepción
Silver complexes bearing substituted terpyridine or tetra-2-pyridinylpyrazine ligands have been prepared and structurally characterised. The study of the anticancer properties of silver complexes with this type of ligands is scarce, despite the possibilities of combining the properties of the metal and the ability of the ligands for DNA binding. Here, the antiproliferative activity, stability, CT-DNA binding and mechanism of cell death of these types of derivatives are studied. High cytotoxicity against different tumour cells was observed, and, more important, a great selectivity index has been detected between tumour cells and healthy Lymphocytes T for some of these compounds. The CT-DNA interaction study has shown that these derivatives are be able to interact with CT-DNA via moderate intercalation. Furthermore, cell death studies indicate that these derivatives promote the apoptosis via mitochondrial pathway.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Antibacterial properties of phosphine gold(i) complexes with 5-fluorouracil

  • Ferrando, Ricardo
  • Mitchell, Scott G.
  • Atrián-Blasco, Elena
  • Cerrada, Elena
New gold(I) complexes with coordination to 5-fluorouracil (5-FU), an anticancer drug with antibacterial properties, have been synthesised and characterised, and are the first reported examples of 5-FU–Au compounds. These new complexes show high solution stability, even in the presence of a cysteine derivative, and so were evaluated as antibacterial compounds against model Gram-positive and Gram-negative bacteria. All the complexes show excellent antibacterial activity against Gram-positive B. subtilis, most of them improving the activity of 5-FU alone. Furthermore, these new complexes are also active against Gram-negative E. coli, where [Au(5-FU)(PTA)], the complex with the smallest phosphane, is the most bactericidal, 32 times more active than 5-FU on its own.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Synthesis of new thiourea-metal complexes with promising anticancer properties

  • Canudo Barreras G.
  • Ortego L.
  • Izaga, A.
  • Marzo Rubio I.
  • Pérez Herrera R.
  • Gimeno M.C.
In this work, two thiourea ligands bearing a phosphine group in one arm and in the other a phenyl group (T2) or 3, 5-di-CF3 substituted phenyl ring (T1) have been prepared and their coordination to Au and Ag has been studied. A different behavior is observed for gold complexes, a linear geometry with coordination only to the phosphorus atom or an equilibrium between the linear and three-coordinated species is present, whereas for silver complexes the coordination of the ligand as PˆS chelate is found. The thiourea ligands and their complexes were explored against different cancer cell lines (HeLa, A549, and Jurkat). The thiourea ligands do not exhibit relevant cytotoxicity in the tested cell lines and the coordination of a metal triggers excellent cytotoxic values in all cases. In general, data showed that gold complexes are more cytotoxic than the silver compounds with T1, in particular the complexes [AuT1(PPh3)]OTf, the bis(thiourea) [Au(T1)2 ]OTf and the gold-thiolate species [Au(SR)T1]. In contrast, with T2 better results are obtained with silver species [AgT1(PPh3)]OTf and the [Ag(T1)2 ]OTf. The role played by the ancillary ligand bound to the metal is important since it strongly affects the cytotoxic activity, being the bis(thiourea) complex the most active species. This study demonstrates that metal complexes derived from thiourea can be biologically active and these compounds are promising leads for further development as potential anticancer agents.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Dual emissive ir(Iii) complexes for photodynamic therapy and bioimaging

  • Redrado M.
  • Benedi A.
  • Marzo I.
  • Gimeno M.C.
  • Fernández-Moreira V.
Photodynamic therapy (PDT) is a cancer treatment still bearing enormous prospects of improvement. Within the toolbox of PDT, developing photosensitizers (PSs) that can specifically reach tumor cells and promote the generation of high concentration of reactive oxygen species (ROS) is a constant research goal. Mitochondria is known as a highly appealing target for PSs, thus being able to assess the biodistribution of the PSs prior to its light activation would be crucial for therapeutic maximization. Bifunctional Ir(III) complexes of the type [Ir(CˆN)2 (NˆN-R)]+, where NˆC is either phenylpyridine (ppy) or benzoquinoline (bzq), NˆN is 2, 2'-dipyridylamine (dpa) and R either anthracene (1 and 3) or acridine (2 and 4), have been developed as novel trackable PSs agents. Activation of the tracking or therapeutic function could be achieved specifically by irradiating the complex with a different light wavelength (405 nm vs. 470 nm respectively). Only complex 4 ([Ir(bzq)2(dpa-acr)]+) clearly showed dual emissive pattern, acridine based emission between 407–450 nm vs. Ir(III) based emission between 521 and 547 nm. The sensitivity of A549 lung cancer cells to 4 evidenced the importance of involving the metal center within the activation process of the PS, reaching values of photosensitivity over 110 times higher than in dark conditions. Moreover, complex 4 promoted apoptotic cell death and possibly the paraptotic pathway, as well as higher ROS generation under irradiation than in dark conditions. Complexes 2–4 accumulated in the mitochondria but species 2 and 4 also localizes in other subcellular organelles.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Piano-Stool Ruthenium(II) Complexes with Delayed Cytotoxic Activity: Origin of the Lag Time

  • Rafols L.
  • Josa D.
  • Aguilà D.
  • Barrios L.A.
  • Roubeau O.
  • Cirera J.
  • Soto-Cerrato V.
  • Pérez-Tomás R.
  • Martínez M.
  • Grabulosa A.
  • Gamez P.
We have recently reported a series of piano-stool ruthenium(II) complexes of the general formula [RuCl2(¿6-arene)(P(1-pyrenyl)R2R3)] showing excellent cytotoxic activities (particularly when R2 = R3 = methyl). In the present study, new members of this family of compounds have been prepared with the objective to investigate the effect of the steric hindrance of a bulky phosphane ligand, namely diisopropyl(1-pyrenyl)phosphane (L), on exchange reactions involving the coordinated halides (X = Cl, I). Two ¿6-arene rings were used, i.e. ¿6-methyl benzoate (mba) and ¿6-p-cymene (p-cym), and four complexes were synthesized, namely [RuCl2(mba)(L)] (1Cl2iPr), [RuI2(mba)(L)] (1I2iPr), [RuCl2(p-cym)(L)] (2Cl2iPr), and [RuI2(p-cym)(L)] (2I2iPr). Unexpectedly, all of the complexes exhibited poor cytotoxic activities after 24 h of incubation with cells, in contrast to the related compounds previously reported. However, it was observed that aged DMSO solutions of 2I2iPr (from 2 to 7 days) exhibited better activities in comparison to freshly prepared solutions and that the activity improved over "aging"time. Thorough studies were therefore performed to uncover the origin of this lag time in the cytotoxicity efficiency. The data achieved clearly demonstrated that compounds 2I2iPr and 2Cl2iPr were undergoing a series of transformation reactions in DMSO (with higher rates for the iodido complex 2I2iPr), ultimately generating cyclometalated species through a mechanism involving DMSO as a coordinated proton abstractor. The cyclometalated complexes detected in solution were subsequently prepared; hence, pure [RuCl(p-cym)(¿2C-diisopropyl(1-pyrenyl)phosphane)] (3CliPr), [RuI(p-cym)(¿2C-diisopropyl(1-pyrenyl)phosphane)] (3IiPr), and [Ru(p-cym)(¿S-dmso)(¿2C-diisopropyl(1-pyrenyl)phosphane)]PF6 (3dmsoiPr) were synthesized and fully characterized. Remarkably, 3CliPr, 3IiPr, and 3dmsoiPr are all very efficient cytotoxic agents, exhibiting slightly better activities in comparison to the chlorido noncyclometalated complexes [RuCl2(¿6-arene)(P(1-pyrenyl)R2R3)] described in an earlier report. For comparison purposes, the iodido compounds [RuI2(mba)(dimethyl(1-pyrenyl)phosphane)] (1I2Me) and [RuI2(p-cym)(dimethyl(1-pyrenyl)phosphane)] (2I2Me), bearing the less hindered dimethyl(1-pyrenyl)phosphane ligand, have also been prepared. The cytotoxic and chemical behaviors of 1I2Me and 1I2Me were comparable to those of their chlorido counterparts reported previously.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Antitumour activity of coordination polymer nanoparticles

  • Suárez García, Salvio|||0000-0002-4156-0579
  • Solorzano Rodriguez, Ruben|||0000-0001-7821-7144
  • Alibés, Ramon|||0000-0002-7997-2691
  • Busqué, Félix|||0000-0001-7566-4264
  • Novio, Fernando|||0000-0002-1517-3612
  • Ruiz-Molina, Daniel|||0000-0002-6844-8421
Nanoscale coordination polymers (NCPs) have fascinated researchers over the last years. Their intrinsic theranostic properties of metal ions and organic ligands, the encapsulation of several drugs/biomolecules with excellent yields and the surface functionalisation, enhancing their biocompatibility and targeting, have remarkably impacted in prospective drug delivery alternatives in medicine. Moreover, the properties and characteristics of these nanoparticles (NPs) can be fine-tuned thanks to the synthetic flexibility of coordination chemistry. For all these reasons, the number of examples published has grown exponentially over the last years, embracing different disciplines such as molecular electronics, sensors or nanomedicine, among others. Specifically, significant advances in antitumoural applications are reported, one of the areas where this novel family of NPs has experienced a considerable advance. NCPs have accomplished a high sophistication degree and efficiency as theranostic nanoplatforms (i.e., drug delivery carriers and bioimaging probes) with long residence time in the bloodstream, targeting capacities and remarkable cellular internalisation. In this review, an introduction emphasizing the advantages of NPs for cancer treatment is included. Later on, the most representative examples of NCPs for antitumoural applications are described grouped into six mean representative areas: i) encapsulation approaches, ii) stimuli-responsive NCPs, iii) metal chemotherapy, iv) photodynamic therapy (PDT), v) unconventional therapeutic approaches and vi) theranostics. Particular emphasis is given to understand the encapsulation/release properties of these particles at the nanoscale and their interaction with biological environments, highlighting any limitation and challenges that these systems are facing from a clinical translation perspective and envisioning possible future trends and areas that will deserve further attention for the following years.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Synthesis and Validation of a Bioinspired Catechol-Functionalized Pt(IV) Prodrug for Preclinical Intranasal Glioblastoma Treatment

  • Mao, Xiaoman
  • Wu, Shuang|||0000-0001-7618-5476
  • Calero-Perez, Pilar|||0000-0001-9370-3757
  • Candiota Silveira, Ana Paula|||0000-0002-1523-6505
  • Alfonso Triguero, Paula|||0000-0002-6554-5656
  • Bruna, Jordi|||0000-0001-6895-5047
  • Yuste, Victor José|||0000-0001-5322-9261
  • Lorenzo Rivera, Julia|||0000-0001-5659-6008
  • Novio, Fernando|||0000-0002-1517-3612
  • Ruiz-Molina, Daniel|||0000-0002-6844-8421
Glioblastoma is the most malignant and frequently occurring type of brain tumors in adults. Its treatment has been greatly hampered by the difficulty to achieve effective therapeutic concentration in the tumor sites due to its location and the blood-brain barrier. Intranasal administration has emerged as an alternative for drug delivery into the brain though mucopenetration, and rapid mucociliary clearance still remains an issue to be solved before its implementation. To address these issues, based on the intriguing properties of proteins secreted by mussels, polyphenol and catechol functionalization has already been used to promote mucopenetration, intranasal delivery and transport across the blood-brain barrier. Thus, herein we report the synthesis and study of complex 1, a Pt(IV) prodrug functionalized with catecholic moieties. This complex considerably augmented solubility in contrast to cisplatin and showed a comparable cytotoxic effect on cisplatin in HeLa, 1Br3G and GL261 cells. Furthermore, preclinical in vivo therapy using the intranasal administration route suggested that it can reach the brain and inhibit the growth of orthotopic GL261 glioblastoma. These results open new opportunities for catechol-bearing anticancer prodrugs in the treatment for brain tumors via intranasal administration.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Intranasal Administration of Catechol-Based Pt(IV) Coordination Polymer Nanoparticles for Glioblastoma Therapy

  • Mao, Xiaoman
  • Calero-Perez, Pilar|||0000-0001-9370-3757
  • Montpeyó, David|||0000-0002-0327-2015
  • Bruna, Jordi|||0000-0001-6895-5047
  • Yuste, Victor José|||0000-0001-5322-9261
  • Candiota Silveira, Ana Paula|||0000-0002-1523-6505
  • Lorenzo Rivera, Julia|||0000-0001-5659-6008
  • Novio, Fernando|||0000-0002-1517-3612
  • Ruiz-Molina, Daniel|||0000-0002-6844-8421
Cisplatin has been described as a potent anticancer agent for decades. However, in the case of glioblastomas, it is only considered a rescue treatment applied after the failure of second-line treatments. Herein, based on the versatility offered by coordination chemistry, we engineered nanoparticles by reaction of a platinum (IV) prodrug and iron metal ions showing in vitro dual pH- and redox-sensitivity, controlled release and comparable cytotoxicity to cisplatin against HeLa and GL261 cells. In vivo intranasal administration in orthotopic preclinical GL261 glioblastoma tumor-bearing mice demonstrated increased accumulation of platinum in tumors, leading in some cases to complete cure and prolonged survival of the tested cohort. This was corroborated by a magnetic resonance imaging follow-up, thus opening new opportunities for intranasal glioblastoma therapies while minimizing side effects. The findings derived from this research showed the potentiality of this approach as a novel therapy for glioblastoma treatment.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Photoactivable Ruthenium-Based Coordination Polymer Nanoparticles for Light-Induced Chemotherapy

  • Zhang, Junda|||0000-0001-8483-2928
  • Ramu, Vadde|||0000-0003-0726-6920
  • Zhou, Xue-Quan
  • Frias, Carolina
  • Ruiz-Molina, Daniel|||0000-0002-6844-8421
  • Bonnet, Sylvestre|||0000-0002-5810-3657
  • Roscini, Claudio|||0000-0002-0157-8934
  • Novio, Fernando|||0000-0002-1517-3612
Green light photoactive Ru-based coordination polymer nanoparticles (CPNs), with chemical formula [[Ru(biqbpy)](bis)](PF) (biqbpy = 6,6'-bis[N-(isoquinolyl)-1-amino]-2,2'-bipyridine; bis = bis(imidazol-1-yl)-hexane), were obtained through polymerization of the trans-[Ru(biqbpy)(dmso)Cl]Cl complex (Complex 1) and bis bridging ligands. The as-synthesized CPNs (50 ± 12 nm diameter) showed high colloidal and chemical stability in physiological solutions. The axial bis(imidazole) ligands coordinated to the ruthenium center were photosubstituted by water upon light irradiation in aqueous medium to generate the aqueous substituted and active ruthenium complexes. The UV-Vis spectral variations observed for the suspension upon irradiation corroborated the photoactivation of the CPNs, while High Performance Liquid Chromatography (HPLC) of irradiated particles in physiological media allowed for the first time precisely quantifying the amount of photoreleased complex from the polymeric material. In vitro studies with A431 and A549 cancer cell lines revealed an 11-fold increased uptake for the nanoparticles compared to the monomeric complex [Ru(biqbpy)(N-methylimidazole)](PF) (Complex 2). After irradiation (520 nm, 39.3 J/cm 2), the CPNs yielded up to a two-fold increase in cytotoxicity compared to the same CPNs kept in the dark, indicating a selective effect by light irradiation. Meanwhile, the absence of 1 O production from both nanostructured and monomeric prodrugs concluded that light-induced cell death is not caused by a photodynamic effect but rather by photoactivated chemotherapy.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Advances in preclinical/clinical glioblastoma treatment, can nanoparticles be of help?

  • Ruiz-Molina, Daniel|||0000-0002-6844-8421
  • Mao, Xiaoman
  • Alfonso Triguero, Paula|||0000-0002-6554-5656
  • Lorenzo Rivera, Julia|||0000-0001-5659-6008
  • Bruna, Jordi|||0000-0001-6895-5047
  • Yuste, Victor José|||0000-0001-5322-9261
  • Candiota Silveira, Ana Paula|||0000-0002-1523-6505
  • Novio, Fernando|||0000-0002-1517-3612
Glioblastoma multiforme (GB) is the most aggressive and frequent primary malignant tumor in the central nervous system (CNS), with unsatisfactory and challenging treatment nowadays. Current standard of care includes surgical resection followed by chemotherapy and radiotherapy. However, these treatments do not much improve the overall survival of GB patients, which is still below two years (the 5-year survival rate is below 7%). Despite various approaches having been followed to increase the release of anticancer drugs into the brain, few of them demonstrated a significant success, as the blood brain barrier (BBB) still restricts its uptake, thus limiting the therapeutic options. Therefore, enormous efforts are being devoted to the development of novel nanomedicines with the ability to cross the BBB and specifically target the cancer cells. In this context, the use of nanoparticles represents a promising non-invasive route, allowing to evade BBB and reducing systemic concentration of drugs and, hence, side effects. In this review, we revise with a critical view the different families of nanoparticles and approaches followed so far with this aim.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Exploring the Biological Properties of Zn(II) Bis thiosemicarbazone Helicates

  • Fernández-Fariña, Sandra|||0000-0002-2877-2411
  • Velo-Heleno, Isabel|||0000-0002-1740-1834
  • Carballido, Rocío
  • Martínez-Calvo, Miguel|||0000-0001-7059-0956
  • Barcia, Ramiro
  • Palacios, Òscar|||0000-0002-2987-7303
  • Capdevila, Mercè|||0000-0002-2246-0994
  • González-Noya, Ana M.|||0000-0002-5423-1934
  • Pedrido, Rosa
The design of artificial helicoidal molecules derived from metal ions with biological properties is one of the objectives within metallosupramolecular chemistry. Herein, we report three zinc helicates derived from a family of bis thiosemicarbazone ligands with different terminal groups, Zn(L Me)∙2HO 1, Zn(L Ph)∙2HO 2 and Zn(L PhNO2) 3, obtained by an electrochemical methodology. These helicates have been fully characterized by different techniques, including X-ray diffraction. Biological studies of the zinc(II) helicates such as toxicity assays with erythrocytes and interaction studies with proteins and oligonucleotides were performed, demonstrating in all cases low toxicity and an absence of covalent interaction with the proteins and oligonucleotides. The in vitro cytotoxicity of the helicates was tested against MCF-7 (human breast carcinoma), A2780 (human ovarian carcinoma cells), NCI-H460 (human lung carcinoma cells) and MRC-5 (normal human lung fibroblasts), comparing the IC values with cisplatin. We will try to demonstrate if the terminal substituent of the ligand precursor exerts any effect in toxicity or in the antitumor activity of the zinc helicates.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Platinum-Based Nanoformulations for Glioblastoma Treatment, The Resurgence of Platinum Drugs?

  • Alfonso Triguero, Paula|||0000-0002-6554-5656
  • Lorenzo Rivera, Julia|||0000-0001-5659-6008
  • Candiota Silveira, Ana Paula|||0000-0002-1523-6505
  • Arús i Caraltó, Carles|||0000-0003-2510-2671
  • Ruiz-Molina, Daniel|||0000-0002-6844-8421
  • Novio, Fernando|||0000-0002-1517-3612
Current therapies for treating Glioblastoma (GB), and brain tumours in general, are inefficient and represent numerous challenges. In addition to surgical resection, chemotherapy and radiotherapy are presently used as standards of care. However, treated patients still face a dismal prognosis with a median survival below 15-18 months. Temozolomide (TMZ) is the main chemotherapeutic agent administered; however, intrinsic or acquired resistance to TMZ contributes to the limited efficacy of this drug. To circumvent the current drawbacks in GB treatment, a large number of classical and non-classical platinum complexes have been prepared and tested for anticancer activity, especially platinum (IV)-based prodrugs. Platinum complexes, used as alkylating agents in the anticancer chemotherapy of some malignancies, are though often associated with severe systemic toxicity (i.e., neurotoxicity), especially after long-term treatments. The objective of the current developments is to produce novel nanoformulations with improved lipophilicity and passive diffusion, promoting intracellular accumulation, while reducing toxicity and optimizing the concomitant treatment of chemo-/radiotherapy. Moreover, the blood-brain barrier (BBB) prevents the access of the drugs to the brain and accumulation in tumour cells, so it represents a key challenge for GB management. The development of novel nanomedicines with the ability to (i) encapsulate Pt-based drugs and pro-drugs, (ii) cross the BBB, and (iii) specifically target cancer cells represents a promising approach to increase the therapeutic effect of the anticancer drugs and reduce undesired side effects. In this review, a critical discussion is presented concerning different families of nanoparticles able to encapsulate platinum anticancer drugs and their application for GB treatment, emphasizing their potential for increasing the effectiveness of platinum-based drugs.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Roadmap on nanomedicine for the central nervous system

  • Ciofani, Gianni|||0000-0003-1192-3647
  • Campisi, Marco
  • Mattu, Clara
  • Kamm, Roger D.|||0000-0002-7232-304X
  • Chiono, Valeria|||0000-0003-2067-7732
  • Raynold, Aji Alex Moothedathu
  • Freitas, João S.
  • Redolfi Riva, Eugenio
  • Micera, Silvestro|||0000-0003-4396-8217
  • Pucci, Carlotta
  • Novio, Fernando|||0000-0002-1517-3612
  • Lorenzo Rivera, Julia|||0000-0001-5659-6008
  • Ruiz-Molina, Daniel|||0000-0002-6844-8421
  • Sierri, Giulia
  • Re, Francesca
  • Wunderlich, Hannah
  • Kumari, Prachi
  • Kozielski, Kristen L.|||0000-0003-3504-2318
  • Chami, Mounia|||0000-0003-1498-7187
  • Marino, Attilio
  • Ferreira, Lino|||0000-0001-8985-9302
In recent years, a great deal of effort has been undertaken with regards to treatment of pathologies at the level of the central nervous system (CNS). Here, the presence of the blood-brain barrier acts as an obstacle to the delivery of potentially effective drugs and makes accessibility to, and treatment of, the CNS one of the most significant challenges in medicine. In this Roadmap article, we present the status of the timeliest developments in the field, and identify the outstanding challenges and opportunities that exist. The format of the Roadmap, whereby experts in each discipline share their viewpoint and present their vision, reflects the dynamic and multidisciplinary nature of this research area, and is intended to generate dialogue and collaboration across traditional subject areas. It is stressed here that this article is not intended to act as a comprehensive review article, but rather an up-to-date and forward-looking summary of research methodologies pertaining to the treatment of pathologies at the level of the CNS.